<!doctype html>
<html lang="zh-Hant">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>暗色模式：文件閱讀器（含目錄）</title>
<style>
  :root {
    --bg:#0b0f14;
    --panel:#101720;
    --muted:#7f8ea3;
    --text:#e6edf3;
    --accent:#4ea1ff;
    --accent-2:#8ab4ff;
    --border:#1b2735;
    --ring:#2b6cb0;
    --code-bg:#0f1621;
  }
  html, body {
    margin:0; padding:0;
    background:var(--bg);
    color:var(--text);
    font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Noto Sans TC, Roboto, Helvetica, Arial, "Apple Color Emoji","Segoe UI Emoji";
    line-height:1.7;
  }
  .layout {
    display:grid;
    grid-template-columns: 300px 1fr;
    gap:0;
    min-height:100vh;
  }
  .sidebar {
    position:sticky; top:0; height:100vh; overflow:auto;
    padding:20px 16px;
    background:var(--panel);
    border-right:1px solid var(--border);
  }
  .brand {
    font-weight:700; letter-spacing:.5px;
    margin-bottom:12px;
  }
  .search {
    width:100%; box-sizing:border-box;
    padding:10px 12px; border-radius:10px;
    border:1px solid var(--border);
    background:#0d141c; color:var(--text);
    outline:none;
  }
  nav ul { list-style:none; padding-left:0; margin:8px 0 0 0; }
  nav li { margin:6px 0; }
  nav a {
    color:var(--muted); text-decoration:none; display:block; padding:6px 10px; border-radius:8px;
  }
  nav a:hover { color:var(--text); background:rgba(78,161,255,.08); }
  nav a.active { color:var(--accent); background:rgba(78,161,255,.12); }
  .toc-l2 { margin-left:10px; }
  .toc-l3 { margin-left:20px; }
  .toc-l4 { margin-left:30px; }
  .toc-l5 { margin-left:40px; }
  .toc-l6 { margin-left:50px; }

  .content {
    padding:28px  min(7vw,60px);
    max-width:1100px;
  }
  .doc header.sticky {
    position:sticky; top:0; z-index:10; padding:10px 0;
    background:linear-gradient(to bottom, var(--bg), rgba(11,15,20,0.85) 60%, transparent);
    backdrop-filter: blur(3px);
  }
  .doc h1, .doc h2, .doc h3, .doc h4, .doc h5, .doc h6 { scroll-margin-top: 80px; }
  .doc h1 { font-size:1.9rem; border-bottom:1px solid var(--border); padding-bottom:8px; margin-top:28px; }
  .doc h2 { font-size:1.5rem; margin-top:26px; }
  .doc h3 { font-size:1.25rem; margin-top:22px; color:var(--accent-2);}
  .doc p { margin:10px 0; }
  .doc code { background:var(--code-bg); padding:2px 6px; border-radius:6px; }
  .doc pre { background:var(--code-bg); padding:14px; border-radius:12px; overflow:auto; }
  .doc hr { border:0; border-top:1px solid var(--border); margin:24px 0; }

  .topbar {
    display:flex; align-items:center; gap:12px;
    border-bottom:1px solid var(--border);
    padding-bottom:10px;
    margin-bottom:10px;
  }
  .topbar .btn {
    display:inline-flex; align-items:center; gap:8px;
    border:1px solid var(--border); background:#0d141c; color:var(--text);
    padding:8px 12px; border-radius:10px; cursor:pointer;
  }
  .topbar .btn:hover { border-color:var(--accent); color:var(--accent); }
  .muted { color:var(--muted); }
  @media (max-width: 900px) {
    .layout { grid-template-columns: 1fr; }
    .sidebar { position:relative; height:auto; }
  }
</style>
</head>
<body>
<div class="layout">
  <aside class="sidebar">
    <div class="brand">📖 文件目錄</div>
    <input id="tocFilter" class="search" placeholder="快速搜尋標題…" />
    <nav id="toc"></nav>
    <div style="margin-top:16px; font-size:.9em;" class="muted">
      按下 <kbd>Ctrl</kbd>/<kbd>⌘</kbd> + <kbd>K</kbd> 亦可快速搜尋標題。
    </div>
  </aside>
  <main class="content">
    <div class="doc">
      <header class="sticky">
        <div class="topbar">
          <button id="collapseAll" class="btn">全部展開/摺疊</button>
          <span class="muted">暗色模式．含左側目錄及錨點導航</span>
        </div>
      </header>
      <hr/>

<hr/>

<h2 id="嗜酸乳桿菌與雙歧桿菌補充對小鼠空間學習與記憶之影響"><strong>嗜酸乳桿菌與雙歧桿菌補充對小鼠空間學習與記憶之影響</strong></h2>

<h2 id="以莫里斯水迷宮實驗為依據"><strong>——以莫里斯水迷宮實驗為依據</strong></h2>

<p><strong>摘要</strong></p>

<p>近年來，「腸-腦軸線」（Gut-Brain Axis）已成為神經科學的熱點領域，腸道菌群被證實能透過多種途徑影響宿主的認知功能與情緒狀態。其中，特定益生菌菌株（又稱「精神益生菌」，Psychobiotics）在改善學習與記憶方面的潛力備受關注。本研究旨在探討特定益生菌組合——嗜酸乳桿菌 (<em>Lactobacillus acidophilus</em>) 與雙歧桿菌 (<em>Bifidobacterium bifidum</em>)——補充對健康 C57BL/6J 雄性小鼠空間學習與記憶能力的影響，並初步探討其潛在的神經生物學機制。</p>

<p>本研究採用隨機分組方式，將 30 隻 8 週齡 C57BL/6J 雄性小鼠分為三組：對照組（Vehicle, n=10）、低劑量益生菌組（Pro-L, $1 \\times 10^8$ CFU/day, n=10）及高劑量益生菌組（Pro-H, $1 \\times 10^9$ CFU/day, n=10）。益生菌組每日經管餵投予 <em>L. acidophilus</em> 與 <em>B. bifidum</em> (1:1 混合) 懸浮液，對照組則給予等量生理食鹽水，持續 6 週。介入結束後，採用莫里斯水迷宮（Morris Water Maze, MWM）進行為期 5 天的定位巡迴訓練及 1 天的空間探測試驗，以評估小鼠的空間學習與記憶能力。實驗結束後，採集海馬迴組織，利用 ELISA 檢測腦源性神經營養因子 (BDNF) 及發炎因子 (TNF-$\\alpha$, IL-6) 的水平。</p>

<p>MWM 定位巡迴訓練結果顯示，隨著訓練天數增加，三組小鼠的逃脫潛伏期均顯著縮短。然而，自第 3 天起，高劑量益生菌組 (Pro-H) 的逃脫潛伏期顯著低於對照組 ($p \&lt; 0.05$)。在第 6 天的空間探測試驗中，Pro-H 組小鼠在目標象限的停留時間顯著高於對照組 ($p \&lt; 0.01$)，且穿越原平台位置的次數也顯著增加 ($p \&lt; 0.05$)。低劑量組 (Pro-L) 則未顯示出顯著差異。機制分析顯示，Pro-H 組小鼠海馬迴中 BDNF 的表達水平顯著高於對照組 ($p \&lt; 0.05$)，而促炎因子 TNF-$\\alpha$ 的水平則顯著降低 ($p \&lt; 0.05$)。</p>

<p>本研究結果證實，高劑量補充嗜酸乳桿菌與雙歧桿菌的特定組合，能顯著提升健康小鼠的空間學習效率與記憶鞏固能力。此效應可能與其增強海馬迴的神經可塑性（提升 BDNF）及降低神經炎症（抑制 TNF-$\\alpha$）有關。本研究為特定益生菌組合作為認知功能促進劑提供了實驗依據。</p>

<p><strong>關鍵詞：</strong> 嗜酸乳桿菌、雙歧桿菌、莫里斯水迷宮、空間學習與記憶、腸-腦軸線、腦源性神經營養因子 (BDNF)</p>

<hr/>

<h2 id="第一章緒論introduction"><strong>第一章 緒論 (Introduction)</strong></h2>

<h3 id="11研究背景與動機"><strong>1.1 研究背景與動機</strong></h3>

<p>大腦與腸道，這兩個看似功能迥異的器官，近年來被證實存在著一個複雜且動態的雙向溝通網絡——「腸-腦軸線」（Gut-Brain Axis）(Cryan et al., 2019)。這個系統整合了神經、內分泌、免疫及代謝等多重通路，使腸道菌群（Gut Microbiota）得以深刻影響宿主的中樞神經系統功能，包括情緒調節、壓力反應，乃至於學習與記憶等高級認知功能 (Mayer et al., 2022)。</p>

<p>腸道菌群的失衡（Dysbiosis）被發現與多種神經系統疾病，如憂鬱症、焦慮症、帕金SON氏症及阿茲海默症（AD）的病理過程密切相關 (Vogt et al., 2017)。反之，透過調節腸道菌群來改善中樞神經系統功能的策略，已成為轉化醫學的新興方向。其中，「益生菌」（Probiotics），特別是那些被證實對心理健康有益的菌株，被稱為「精神益生菌」（Psychobiotics），正受到越來越多的關注 (Dinan et al., 2013)。</p>

<p>在眾多益生菌中，乳桿菌屬 (<em>Lactobacillus</em>) 和雙歧桿菌屬 (<em>Bifidobacterium</em>) 是研究最為廣泛的兩類。<em>Lactobacillus</em> 菌株被報導能調節神經遞質 GABA 的水平，而 <em>Bifidobacterium</em> 菌株則被發現能影響血清素的生成，並具備抗發炎特性 (Bravo et al., 2011; Desbonnet et al., 2010)。已有動物實驗顯示，補充特定 <em>Lactobacillus</em> 或 <em>Bifidobacterium</em> 菌株，能改善壓力或疾病模型（如 AD 模型）小鼠的認知缺陷 (Bonfili et al., 2017)。然而，這些研究多集中於病理狀態下的「修復」作用，對於健康個體是否具有「提升」認知功能的效應，目前的研究仍相對有限且結論不一。</p>

<p>此外，益生菌的作用具有高度的「菌株特異性」（Strain-specific）與「劑量依賴性」（Dose-dependent），且不同菌株的組合可能產生協同效應。嗜酸乳桿菌 (<em>Lactobacillus acidophilus</em>) 與雙歧桿菌 (<em>Bifidobacterium bifidum</em>) 是腸道中的優勢菌種，兩者在維持腸道屏障完整性及免疫調節上均扮演重要角色。探討這兩種特定菌株組合對健康小鼠認知功能的影響，對於開發新型態的認知保健補充品具有重要意義。</p>

<h3 id="12研究目的"><strong>1.2 研究目的</strong></h3>

<p>評估學習與記憶能力，特別是空間學習，是神經科學的經典課題。空間學習與記憶高度依賴海馬迴（Hippocampus）的功能 (O'Keefe &amp; Nadel, 1978)。莫里斯水迷宮（Morris Water Maze, MWM）實驗是評估囓齒類動物海馬迴依賴性空間學習與記憶能力的黃金標準 (Morris, 1984)。它能精確量化動物的學習曲線（Acquisition）與長期記憶的鞏固（Consolidation）。</p>

<p>因此，本研究旨在利用莫里斯水迷宮實驗，系統性地評估特定益生菌組合——<em>L. acidophilus</em> 與 <em>B. bifidum</em>——補充對健康 C57BL/6J 小鼠空間學習與記憶能力的影響。</p>

<p>具體研究目的條列如下：</p>

<ol>
<li>探討連續 6 週補充 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合，是否能提升健康小鼠在 MWM 中的<strong>空間學習效率</strong>（即縮短逃脫潛伏期）。</li>
<li>評估此益生菌組合是否能增強健康小鼠的<strong>空間記憶鞏固</strong>（即增加 MWM 探測試驗中目標象限的停留時間）。</li>
<li>探討益生菌介入對海馬迴神經可塑性關鍵分子<strong>腦源性神經營養因子 (BDNF)</strong> 及<strong>神經炎症因子 (TNF-$\\alpha$, IL-6)</strong> 水平的影響，初步探索其潛在作用機制。</li>
</ol>

<h3 id="13研究假設"><strong>1.3 研究假設</strong></h3>

<p>基於上述背景與目的，本研究提出以下假設：</p>

<ul>
<li><strong>H1:</strong> 相較於對照組，補充 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合的益生菌組小鼠，在 MWM 學習階段將展現更短的逃脫潛伏期。</li>
<li><strong>H2:</strong> 在 MWM 探測試驗中，益生菌組小鼠在目標象限的停留時間將顯著高於對照組。</li>
<li><strong>H3:</strong> 益生菌的補充將顯著提升小鼠海馬迴中 BDNF 的表達水平，並降低 TNF-$\\alpha$ 與 IL-6 的水平，此效應在高劑量組中更為顯著。</li>
</ul>

<p>本研究的成果將有助於釐清特定益生菌組合在調節腸-腦軸線、促進健康個體認知功能方面的作用，並為未來相關保健品的開發提供科學依據。</p>

<hr/>

<h2 id="第二章文獻探討literaturereview"><strong>第二章 文獻探討 (Literature Review)</strong></h2>

<p>本章旨在奠定研究的理論基礎，系統性回顧空間學習記憶的生物學基礎、MWM 實驗方法的應用、腸-腦軸線的核心概念，以及益生菌對認知功能影響的相關實證研究，最終明確本研究的學術定位與研究缺口。</p>

<h3 id="21空間學習與記憶的生物學基礎"><strong>2.1 空間學習與記憶的生物學基礎</strong></h3>

<p>學習與記憶是中樞神經系統最高級的功能之一。根據訊息的性質與持續時間，記憶可被分為多種類型。空間學習與記憶（Spatial Learning and Memory）屬於陳述性記憶（Declarative memory）的一種，特指個體獲取、儲存和回憶環境中物體相對位置和導航路徑的能力 (Bird &amp; Burgess, 2008)。</p>

<h4 id="211學習記憶的分子機制與海馬迴"><strong>2.1.1 學習記憶的分子機制與海馬迴</strong></h4>

<p>在分子層面上，學習與記憶的形成被認為是突觸可塑性（Synaptic Plasticity）的結果，即神經元之間連接強度的改變。其中，「長期增益效應」（Long-Term Potentiation, LTP）是目前被公認最為重要的機制之一 (Bliss &amp; Lømo, 1973)。LTP 指的是突觸後神經元對突觸前刺激產生持久且增強的反應，此過程涉及 NMDA 受體的活化、鈣離子內流，以及後續一系列蛋白質激酶（如 CaMKII）的活化，最終導致 AMPA 受體數量增加或功能增強。</p>

<h4 id="212腦源性神經營養因子bdnf的角色"><strong>2.1.2 腦源性神經營養因子 (BDNF) 的角色</strong></h4>

<p>在維持 LTP 和突觸可塑性中，腦源性神經營養因子 (BDNF) 扮演著至關重要的角色。BDNF 是一種神經營養蛋白，在成人大腦中，尤其在海馬迴和皮質中高表達。BDNF 不僅促進神經元的存活、分化和生長，更直接參與突觸的成熟與功能調節 (Poo, 2001)。研究表明，BDNF 水平的提升與學習記憶能力的增強密切相關，而 BDNF 水平的下降則與多種神經退化性疾病中的認知衰退有關。</p>

<h4 id="213空間學習的核心腦區海馬迴"><strong>2.1.3 空間學習的核心腦區：海馬迴</strong></h4>

<p>海馬迴（Hippocampus）被公認為空間學習與記憶的關鍵腦區。O'Keefe 與 Nadel (1978) 提出的「認知地圖」（Cognitive Map）理論指出，海馬迴中的「位置細胞」（Place Cells）負責編碼動物在環境中所處的特定位置，從而構建一張內在的空間地圖。當動物在環境中導航時，這些細胞會選擇性地放電。海馬迴的損傷會導致嚴重的空間導航障礙，這在動物模型和人類患者中均得到了證實。</p>

<h3 id="22莫里斯水迷宮morriswatermazemwm實驗方法"><strong>2.2 莫里斯水迷宮 (Morris Water Maze, MWM) 實驗方法</strong></h3>

<p>為了有效評估海馬迴依賴的空間學習記憶，Richard Morris 於 1984 年設計了莫里斯水迷宮（MWM）實驗。此方法迅速成為行為神經科學的黃金標準，因其能有效排除嗅覺線索的干擾，且動物的動機（逃離水）相對恆定 (Morris, 1984)。</p>

<p>MWM 實驗通常包括一個圓形水池，池水被染成不透明，池中隱藏一個略低於水面的逃生平台。水池周圍佈置有固定的、遠距離的視覺線索（Extra-maze Cues）。</p>

<ol>
<li><strong>定位巡迴訓練（Acquisition Phase）：</strong> 動物被從不同象限放入水中，必須利用水池外的視覺線索來定位並游向隱藏平台。隨著訓練次數的增加，動物學習定位所需的時間（逃脫潛伏期, Escape Latency）和游泳距離會逐漸縮短，這反映了空間學習曲線。</li>
<li><strong>空間探測試驗（Probe Trial）：</strong> 訓練結束後，移除平台。動物被放入水中游泳一定時間（如 60 秒）。研究者記錄動物在原平台所在象限（目標象限）的停留時間百分比，以及穿越原平台位置的次數。這兩項指標反映了空間記憶的鞏固程度和精確性。</li>
</ol>

<p>MWM 實驗的優勢在於它能清晰地區分學習過程與記憶提取，是評估潛在認知增強劑（如益生菌）效用的理想工具。</p>

<h3 id="23益生菌probiotics及其在腸-腦軸線中的作用"><strong>2.3 益生菌 (Probiotics) 及其在腸-腦軸線中的作用</strong></h3>

<h4 id="231益生菌與精神益生菌的定義"><strong>2.3.1 益生菌與精神益生菌的定義</strong></h4>

<p>益生菌被定義為「當攝取足夠數量時，能對宿主健康產生有益作用的活性微生物」(Hill et al., 2014)。而「精神益生菌」（Psychobiotics）則特指那些能對宿主產生心理健康益處、影響腸-腦軸線功能的益生菌 (Dinan et al., 2013)。</p>

<h4 id="232腸-腦軸線gut-brainaxis的雙向溝通路徑"><strong>2.3.2 腸-腦軸線 (Gut-Brain Axis) 的雙向溝通路徑</strong></h4>

<p>腸道菌群透過多種途徑與大腦進行雙向溝通，這些途徑共同構成了腸-腦軸線：</p>

<ol>
<li><strong>神經通路：</strong> 主要是迷走神經（Vagus Nerve）。腸道中的細菌代謝物或細胞壁成分能刺激腸道內的感覺神經元，訊號經由迷走神經傳入中樞神經系統 (Bravo et al., 2011)。</li>
<li><strong>免疫通路：</strong> 腸道菌群是宿主免疫系統的主要調節者。菌群失衡可能導致腸道屏障受損（「腸漏症」），細菌脂多醣 (LPS) 等內毒素進入血液，引發全身性低度發炎，並進一步導致神經炎症（Neuroinflammation），損害海馬迴功能 (Ma et al., 2019)。</li>
<li><strong>內分泌/代謝通路：</strong> 腸道菌群能合成或調節多種神經活性物質。例如，某些菌群能產生短鏈脂肪酸（Short-Chain Fatty Acids, SCFAs），如丁酸鹽，SCFAs 不僅是腸道細胞的能量來源，還能穿過血腦屏障，調節海馬迴中 BDNF 的表達 (Dalile et al., 2019)。此外，腸道菌群參與色胺酸代謝，影響中樞神經系統中血清素（Serotonin）的合成。</li>
</ol>

<h4 id="233嗜酸乳桿菌lacidophilus與雙歧桿菌bbifidum的特性">**2.3.3 嗜酸乳桿菌 (<em>L. acidophilus</em>) 與雙歧桿菌 (<em>B. bifidum</em>) 的特性**</h4>

<ul>
<li>**嗜酸乳桿菌 (<em>L. acidophilus</em>)：** 作為最著名的乳桿菌之一，<em>L. acidophilus</em> 以其強大的腸道定殖能力和免疫調節作用而聞名。研究發現，特定 <em>L. acidophilus</em> 菌株能調節犬尿氨酸途徑（Kynurenine pathway），減少神經毒性代謝物的產生，並可能透過影響 GABA 受體表達來發揮抗焦慮作用 (Wang et al., 2019)。</li>
<li>**雙歧桿菌 (<em>B. bifidum</em>)：** 雙歧桿菌是嬰幼兒腸道中的優勢菌種，被認為與早期神經發育有關。<em>B. bifidum</em> 菌株被證實具有強大的抗發炎能力，能抑制促炎因子（如 TNF-$\\alpha$, IL-6）的產生，並修復受損的腸道屏障 (Pinto-Sanchez et al., 2017)。</li>
</ul>

<h3 id="24益生菌補充對學習與記憶的影響相關實證研究"><strong>2.4 益生菌補充對學習與記憶的影響：相關實證研究</strong></h3>

<p>近年來，越來越多的動物實驗開始探討益生菌對認知功能的影響。</p>

<ul>
<li><strong>在病理模型中：</strong> 多項研究集中於阿茲海默症（AD）或衰老動物模型。例如，Bonfili 等人 (2017) 發現，給予 AD 轉基因小鼠 (3xTg-AD) 含有乳桿菌和雙歧桿菌的複合益生菌（SLAB51），能顯著改善其在 MWM 中的表現，並減少海馬迴中的 A$\\beta$ 斑塊沉積。</li>
<li><strong>在壓力模型中：</strong> 壓力是導致認知功能下降的常見因素。研究顯示，補充 <em>L. helveticus</em> 和 <em>B. longum</em> 的組合能減輕慢性壓力大鼠的焦慮樣行為，並改善其空間記憶缺陷 (Messaoudi et al., 2011)。</li>
<li><strong>在健康動物中：</strong> 關於益生菌對健康動物認知「提升」作用的研究相對較少。Smith 等人 (2022) 的研究（<em>模擬文獻</em>）指出，給予健康 C57BL/6J 小鼠 <em>L. acidophilus</em> NCFM 菌株，能在 MWM 測試中觀察到學習曲線的輕微改善，並伴隨海馬迴 BDNF 的上調。然而，Wang 等人 (2023)（<em>模擬文獻</em>）的研究在使用另一種 <em>Bifidobacterium</em> 菌株時，並未在健康小鼠的 MWM 表現中觀察到顯著差異。</li>
</ul>

<h3 id="25研究缺口與本研究的定位"><strong>2.5 研究缺口與本研究的定位</strong></h3>

<p>綜觀現有文獻，存在以下幾個明顯的研究缺口：</p>

<ol>
<li><strong>菌株組合的協同效應：</strong> 多數研究集中於單一菌株或複雜的複合配方。對於 <em>L. acidophilus</em> 和 <em>B. bifidum</em> 這兩種特定且互補的菌株組合，其對健康個體空間記憶的影響尚不清楚。</li>
<li><strong>劑量-效應關係：</strong> 現有研究中使用的益生菌劑量差異巨大（從 $10^7$ 到 $10^{10}$ CFU/day 不等）。缺乏對 <em>L. acidophilus</em> 和 <em>B. bifidum</em> 組合的劑量-效應關係的系統性探討。</li>
<li><strong>健康狀態下的提升作用：</strong> 如前所述，相較於病理修復，益生菌在健康狀態下的認知「增強」效應需要更多直接且可靠的證據，特別是使用 MWM 這一黃金標準進行的評估。</li>
</ol>

<p>因此，本研究的定位在於填補上述缺口。我們選定 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 這一特定組合，採用兩種不同劑量（低劑量 $10^8$ CFU/day，高劑量 $10^9$ CFU/day），並以健康 C57BL/6J 小鼠為研究對象，利用嚴謹的 MWM 實驗範式，旨在精確評估該益生菌組合在非病理狀態下對空間學習與記憶的潛在提升作用及其可能的機制。</p>

<hr/>

<h2 id="第三章研究方法materialsandmethods"><strong>第三章 研究方法 (Materials and Methods)</strong></h2>

<p>本研究所有實驗流程均嚴格遵守動物福利規範，並已獲得 \[貴機構名稱\] 動物實驗倫理委員會（IACUC）的批准（批准文號：\[模擬文號 IACUC-202X-XXX\]）。</p>

<h3 id="31實驗動物"><strong>3.1 實驗動物</strong></h3>

<h4 id="311動物品系數量與飼養條件"><strong>3.1.1 動物品系、數量與飼養條件</strong></h4>

<p>本研究選用 30 隻 8 週齡的雄性 C57BL/6J 小鼠，購自 \[模擬實驗動物中心名稱\]。C57BL/6J 品系因其穩定的遺傳背景和在 MWM 等行為學測試中表現一致而被廣泛使用。</p>

<p>所有小鼠在 SPF (Specific Pathogen-Free) 等級的動物房中飼養，環境條件控制為：溫度 $22 \\pm 2^\\circ\\text{C}$，相對濕度 $55 \\pm 10\\%$，採 12 小時光照/12 小時黑暗週期（上午 8:00 開燈）。小鼠採群養（每籠 5 隻），可自由獲取標準顆粒飼料和無菌飲用水。所有動物在實驗開始前均有 1 週的適應期。</p>

<h4 id="312分組與隨機化"><strong>3.1.2 分組與隨機化</strong></h4>

<p>30 隻小鼠依據體重採用隨機數字表法分為三組，每組 10 隻 (n=10)：</p>

<ol>
<li><strong>對照組 (Vehicle, CON)：</strong> 投予等體積生理食鹽水。</li>
<li><strong>低劑量益生菌組 (Pro-L)：</strong> 投予 $1 \\times 10^8$ CFU/day 益生菌懸浮液。</li>
<li><strong>高劑量益生菌組 (Pro-H)：</strong> 投予 $1 \\times 10^9$ CFU/day 益生菌懸浮液。</li>
</ol>

<h3 id="32實驗介入物製備與投餵"><strong>3.2 實驗介入物製備與投餵</strong></h3>

<h4 id="321菌株來源與製備"><strong>3.2.1 菌株來源與製備</strong></h4>

<p>本研究使用的嗜酸乳桿菌 (<em>Lactobacillus acidophilus</em>) \[菌株編號，例如 ATCC 4356\] 和雙歧桿菌 (<em>Bifidobacterium bifidum</em>) \[菌株編號，例如 ATCC 29521\] 凍乾粉末購自 \[模擬菌種保存中心或公司\]。</p>

<p>實驗前，將兩種菌株的凍乾粉末以 1:1 的比例（按 CFU 計數）混合，並用無菌生理食鹽水（0.9% NaCl）重懸。每日投餵前新鮮製備，並通過平板計數法確認菌株濃度與存活性。製備好的懸浮液分為兩種濃度：低劑量（$1 \\times 10^9$ CFU/mL）和高劑量（$1 \\times 10^{10}$ CFU/mL）。</p>

<h4 id="322劑量與投餵方式"><strong>3.2.2 劑量與投餵方式</strong></h4>

<p>自第 9 週齡起，每日上午 9:00-10:00 進行管餵 (oral gavage)。</p>

<ul>
<li>Pro-L 組和 Pro-H 組小鼠分別管餵 0.1 mL 的低劑量和高劑量菌液，確保每日攝入總菌數分別為 $1 \\times 10^8$ CFU 和 $1 \\times 10^9$ CFU。</li>
<li>CON 組小鼠管餵 0.1 mL 的生理食鹽水作為安慰劑對照。</li>
</ul>

<p>此介入持續 6 週（42 天）。在整個介入期間，每週記錄小鼠體重及觀察其健康狀況。</p>

<h3 id="33莫里斯水迷宮morriswatermazemwm實驗"><strong>3.3 莫里斯水迷宮 (Morris Water Maze, MWM) 實驗</strong></h3>

<p>益生菌介入 6 週後，開始進行 MWM 實驗。實驗在一個專用的安靜行為學實驗室中進行。</p>

<h4 id="331設備與環境設置"><strong>3.3.1 設備與環境設置</strong></h4>

<p>MWM 設備為一個直徑 120 cm、高 50 cm 的白色圓形水池。水池中注入水，水深 30 cm，水溫維持在 $22 \\pm 1^\\circ\\text{C}$。水中加入無毒的白色食用色素，使水呈不透明，以隱藏平台。  </p>
<p>隱藏平台為一個直徑 10 cm 的白色圓形平台，放置在特定象限（目標象限，例如：東北象限）的中心，平台頂部低於水面 1.5 cm。  </p>
<p>水池周圍的牆壁上懸掛四個不同形狀和顏色的幾何圖形作為遠距離空間線索（Extra-maze Cues），並在整個實驗期間保持位置不變。  </p>
<p>水池正上方架設一台攝影機，連接至 \[模擬軟體名稱，例如 Any-maze 或 EthoVision XT\] 影像追蹤系統，自動記錄小鼠的游泳路徑、速度、潛伏期等參數。</p>

<h4 id="332實驗流程與指標"><strong>3.3.2 實驗流程與指標</strong></h4>

<p>MWM 實驗共進行 6 天。</p>

<ul>
<li><strong>A. 定位巡迴訓練 (Acquisition Phase, Day 1 \- Day 5)：</strong></li>
<li>每天進行 4 次訓練 (4 trials)，每次訓練間隔約 15 分鐘。</li>
<li>4 次訓練的入水點分別位於四個象限（非目標象限除外）的邊緣，順序隨機。</li>
<li>每次訓練開始時，將小鼠面向池壁輕放入水。小鼠需在 60 秒內找到隱藏平台。</li>
<li>若小鼠在 60 秒內找到平台，使其在平台上停留 15 秒以記憶空間線索；若 60 秒內未找到，則由實驗者將其引導至平台，並停留 15 秒。</li>
<li>記錄的指標：<strong>逃脫潛伏期 (Escape Latency)</strong>（找到平台所需時間）和<strong>游泳路徑長度 (Path Length)</strong>。</li>
<li><strong>B. 空間探測試驗 (Probe Trial, Day 6)：</strong></li>
<li>在第 5 天訓練結束後 24 小時進行。</li>
<li>將水池中的平台撤除。</li>
<li>將小鼠從距離目標象限最遠的象限（例如：西南象限）入水，使其自由游泳 60 秒。</li>
<li>記錄的指標：<strong>目標象限停留時間百分比 (Time in Target Quadrant %)</strong> 和 <strong>穿越原平台位置次數 (Platform Crossings)</strong>。</li>
<li><strong>C. 視力與動機測試 (Visible Platform Test, Day 6 探測試驗後)：</strong></li>
<li>為排除益生菌對小鼠視力、運動能力或游泳動機的影響。</li>
<li>在平台上放置一個醒目的標記（例如：紅色小旗），使平台高出水面 1 cm，清晰可見。</li>
<li>將小鼠放入水中，記錄其找到可見平台的時間。若各組間無顯著差異，則可排除上述干擾因素。</li>
</ul>

<h3 id="34組織採樣與生化分析"><strong>3.4 組織採樣與生化分析</strong></h3>

<p>MWM 實驗結束後（Day 7），小鼠經二氧化碳麻醉後，迅速斷頭處死。  </p>
<p>立即冰上分離雙側海馬迴組織，稱重後迅速置於液態氮中速凍，隨後轉移至 $-80^\\circ\\text{C}$ 冰箱保存待用。</p>

<h4 id="341海馬迴組織勻漿"><strong>3.4.1 海馬迴組織勻漿</strong></h4>

<p>取一側海馬迴組織，加入含蛋白酶抑制劑的 RIPA 緩衝液，進行冰上勻漿。勻漿液在 $4^\\circ\\text{C}$ 下以 12,000 rpm 離心 15 分鐘，取上清液。使用 BCA 蛋白定量試劑盒測定總蛋白濃度。</p>

<h4 id="342elisa檢測"><strong>3.4.2 ELISA 檢測</strong></h4>

<p>使用市售的 ELISA 試劑盒（購自 \[模擬廠商，例如 R\&amp;D Systems 或 Abcam\]）檢測海馬迴勻漿上清液中的 BDNF、TNF-$\\alpha$ 和 IL-6 含量。所有操作均嚴格按照試劑盒說明書進行。所有樣本均進行三次重複檢測。最終濃度以 pg/mg 總蛋白表示。</p>

<h3 id="35統計分析"><strong>3.5 統計分析</strong></h3>

<p>所有實驗數據均使用 GraphPad Prism 9.0 軟體進行統計分析與繪圖。數據以<strong>平均值 $\\pm$ 標準誤 (Mean $\\pm$ SEM)</strong> 表示。</p>

<ol>
<li><strong>MWM 學習曲線 (逃脫潛伏期)：</strong> 使用<strong>雙因子重複量數變異數分析 (Two-way RM ANOVA)</strong> 進行分析，組別 (Group) 為組間因子，時間 (Day) 為組內因子。若交互作用顯著，則進行 Bonferroni 事後檢定 (Post-hoc test)。</li>
<li><strong>MWM 探測試驗及生化指標：</strong> 使用<strong>單因子變異數分析 (One-way ANOVA)</strong> 進行組間比較。若 F 值達到顯著水平，則使用 Tukey's HSD 事後檢定進行多重比較。</li>
<li><strong>顯著性水平：</strong> 所有統計檢定的顯著性水平 $p$ 值設定為 $\&lt; 0.05$。</li>
</ol>

<hr/>

<h2 id="第四章研究結果results"><strong>第四章 研究結果 (Results)</strong></h2>

<p>本章將呈現益生菌介入 6 週後，小鼠在 MWM 行為學測試中的表現，以及海馬迴組織中相關神經營養因子與發炎因子的生化檢測結果。</p>

<h3 id="41益生菌介入對小鼠一般狀況的影響"><strong>4.1 益生菌介入對小鼠一般狀況的影響</strong></h3>

<p>在為期 6 週的益生菌介入期間，所有小鼠均健康狀況良好，無明顯不良反應或行為異常。每週的體重監測顯示，三組小鼠（CON, Pro-L, Pro-H）的體重增長曲線無顯著差異（數據未顯示），表明本研究所用劑量的 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合具有良好的生物安全性。</p>

<h3 id="42mwm視力與動機測試結果"><strong>4.2 MWM 視力與動機測試結果</strong></h3>

<p>在第 6 天的 MWM 探測試驗後，我們進行了可見平台測試。結果顯示，三組小鼠找到可見平台的逃脫潛伏期（CON: $10.2 \\pm 1.5$ s; Pro-L: $9.8 \\pm 1.2$ s; Pro-H: $9.5 \\pm 1.1$ s）和游泳速度均無統計學上的顯著差異 (One-way ANOVA, $F(2, 27\) \= 0.15, p \= 0.86$)。此結果排除了益生菌介入對小鼠視力、運動能力或逃避動機產生干擾的可能性，確保了 MWM 空間學習記憶結果的有效性。</p>

<h3 id="43益生菌對mwm空間學習定位巡迴訓練的影響"><strong>4.3 益生菌對 MWM 空間學習（定位巡迴訓練）的影響</strong></h3>

<p>圖 4-1 顯示了三組小鼠在 5 天定位巡迴訓練期間的逃脫潛伏期變化。</p>

<p><em>\[圖 4-1：三組小鼠在 MWM 定位巡迴訓練中的逃脫潛伏期學習曲線。縱軸為逃脫潛伏期（秒），橫軸為訓練天數（Day 1-5）。數據以 Mean $\\pm$ SEM 表示。 $p \&lt; 0.05$ vs. CON 組。\]</em>\*</p>

<p><strong>\[模擬圖表描述\]</strong></p>

<ul>
<li><strong>圖 4-1 模擬數據與描述：</strong></li>
<li><strong>Day 1:</strong> CON ($50.5 \\pm 2.5$s), Pro-L ($49.8 \\pm 3.0$s), Pro-H ($50.1 \\pm 2.8$s)</li>
<li><strong>Day 2:</strong> CON ($38.2 \\pm 2.1$s), Pro-L ($36.5 \\pm 2.5$s), Pro-H ($35.0 \\pm 2.2$s)</li>
<li><strong>Day 3:</strong> CON ($30.1 \\pm 1.8$s), Pro-L ($28.0 \\pm 2.0$s), Pro-H ($24.5 \\pm 1.5$s)\*</li>
<li><strong>Day 4:</strong> CON ($25.5 \\pm 1.5$s), Pro-L ($22.1 \\pm 1.6$s), Pro-H ($18.0 \\pm 1.2$s)\*</li>
<li><strong>Day 5:</strong> CON ($20.1 \\pm 1.2$s), Pro-L ($18.5 \\pm 1.4$s), Pro-H ($14.5 \\pm 1.0$s)\*</li>
</ul>

<p>Two-way RM ANOVA 分析顯示，時間 (Day) 具有顯著的主效應 ($F(4, 108\) \= 85.2, p \&lt; 0.001$)，表明所有組別的小鼠均表現出明顯的學習效應。組別 (Group) 同樣具有顯著的主效應 ($F(2, 27\) \= 5.6, p \&lt; 0.01$)。  </p>
<p>重要的是，時間與組別之間存在顯著的交互作用 ($F(8, 108\) \= 2.8, p \&lt; 0.01$)。  </p>
<p>事後檢定 (Bonferroni) 分析顯示，在訓練的第 1 天和第 2 天，三組之間的逃脫潛伏期沒有顯著差異。然而，從第 3 天開始，Pro-H 組的逃脫潛伏期顯著短於 CON 組（Day 3, $p \&lt; 0.05$; Day 4, $p \&lt; 0.05$; Day 5, $p \&lt; 0.05$）。Pro-L 組的逃脫潛伏期在第 4、5 天有縮短的趨勢，但與 CON 組相比未達到統計學顯著差異。  </p>
<p>此結果表明，高劑量益生菌補充顯著提升了健康小鼠的空間學習效率。</p>

<h3 id="44益生菌對mwm空間記憶探測試驗的影響"><strong>4.4 益生菌對 MWM 空間記憶（探測試驗）的影響</strong></h3>

<p>在第 6 天進行的空間探測試驗中，我們評估了小鼠對原平台位置的記憶鞏固情況（圖 4-2）。</p>

<p><em>\[圖 4-2：三組小鼠在 MWM 空間探測試驗中的表現。(A) 目標象限停留時間百分比 (%)。(B) 穿越原平台位置次數。數據以 Mean $\\pm$ SEM 表示。 $p \&lt; 0.05$, \</em>\<em> $p \&lt; 0.01$ vs. CON 組。\]</em>\*</p>

<p><strong>\[模擬圖表描述\]</strong></p>

<ul>
<li><strong>圖 4-2A (目標象限停留時間 %):</strong></li>
<li>One-way ANOVA 分析顯示組間存在顯著差異 ($F(2, 27\) \= 6.9, p \&lt; 0.01$)。</li>
<li>Tukey's 事後檢定顯示，<strong>Pro-H 組</strong>在目標象限的停留時間（模擬值：$42.5 \\pm 3.1\\%$）顯著高於 CON 組（模擬值：$28.0 \\pm 2.5\\%$）($p \&lt; 0.01$)。</li>
<li>Pro-L 組（模擬值：$31.5 \\pm 2.8\\%$）與 CON 組相比無顯著差異。</li>
<li><strong>圖 4-2B (穿越平台次數):</strong></li>
<li>One-way ANOVA 分析顯示組間存在顯著差異 ($F(2, 27\) \= 4.8, p \&lt; 0.05$)。</li>
<li>Tukey's 事後檢定顯示，<strong>Pro-H 組</strong>穿越原平台位置的次數（模擬值：$4.8 \\pm 0.5$ 次）顯著高於 CON 組（模擬值：$3.0 \\pm 0.4$ 次）($p \&lt; 0.05$)。</li>
<li>Pro-L 組（模擬值：$3.5 \\pm 0.6$ 次）與 CON 組相比無顯著差異。</li>
</ul>

<p>綜合探測試驗結果，高劑量益生菌補充顯著增強了小鼠的空間記憶鞏固能力和搜索精確性。</p>

<h3 id="45益生菌對海馬迴神經因子水平的影響"><strong>4.5 益生菌對海馬迴神經因子水平的影響</strong></h3>

<p>為了探討益生菌改善認知功能的潛在機制，我們檢測了 MWM 實驗後小鼠海馬迴組織中 BDNF、TNF-$\\alpha$ 和 IL-6 的水平（圖 4-3）。</p>

<p><em>\[圖 4-3：三組小鼠海馬迴中 (A) BDNF, (B) TNF-$\\alpha$, (C) IL-6 的蛋白表達水平。數據以 Mean $\\pm$ SEM 表示。 $p \&lt; 0.05$ vs. CON 組。\]</em>\*</p>

<p><strong>\[模擬圖表描述\]</strong></p>

<ul>
<li><strong>圖 4-3A (BDNF):</strong></li>
<li>One-way ANOVA 顯示組間存在顯著差異 ($F(2, 27\) \= 5.1, p \&lt; 0.05$)。</li>
<li>Tukey's 事後檢定顯示，<strong>Pro-H 組</strong>海馬迴 BDNF 水平（模擬值：150.2 $\\pm 10.5$ pg/mg 蛋白）顯著高於 CON 組（模擬值：105.5 \\pm 8.2 pg/mg 蛋白）($p \&lt; 0.05$)。</li>
<li>Pro-L 組（模擬值：120.8 \\pm 9.5 pg/mg 蛋白）有升高趨勢，但未達顯著差異。</li>
<li><strong>圖 4-3B (TNF-$\\alpha$):</strong></li>
<li>One-way ANOVA 顯示組間存在顯著差異 ($F(2, 27\) \= 4.5, p \&lt; 0.05$)。</li>
<li>Tukey's 事後檢定顯示，<strong>Pro-H 組</strong>海馬迴 TNF-$\\alpha$ 水平（模擬值：35.8 $\\pm 3.0$ pg/mg 蛋白）顯著低於 CON 組（模擬值：55.2 \\pm 4.1 pg/mg 蛋白）($p \&lt; 0.05$)。</li>
<li>Pro-L 組（模擬值：48.0 \\pm 3.8 pg/mg 蛋白）與 CON 組無顯著差異。</li>
<li><strong>圖 4-3C (IL-6):</strong></li>
<li>三組間海馬迴 IL-6 水平（模擬值：CON $15.1 \\pm 1.8$; Pro-L $13.5 \\pm 1.5$; Pro-H $12.8 \\pm 1.3$ pg/mg 蛋白）無統計學顯著差異 ($F(2, 27\) \= 0.6, p \= 0.56$)。</li>
</ul>

<p>生化分析結果表明，高劑量益生菌補充可能通過<strong>上調海馬迴 BDNF 水平</strong>（促進神經可塑性）和<strong>下調海馬迴 TNF-$\\alpha$ 水平</strong>（抑制神經炎症）來共同改善空間學習與記憶。</p>

<hr/>

<h2 id="第五章討論discussion"><strong>第五章 討論 (Discussion)</strong></h2>

<p>本研究旨在探討特定益生菌組合（<em>L. acidophilus</em> 與 <em>B. bifidum</em>）對健康小鼠空間學習與記憶的影響。研究結果顯示，高劑量（$1 \\times 10^9$ CFU/day）益生菌補充 6 週，能顯著提升小鼠在 MWM 中的學習效率（縮短第 3-5 天的逃脫潛伏期）和記憶鞏固（增加探測期目標象限停留時間與平台穿越次數）。機制上，此效應伴隨著海馬迴 BDNF 水平的顯著升高和 TNF-$\\alpha$ 水平的顯著降低。</p>

<h3 id="51主要發現與研究假設驗證"><strong>5.1 主要發現與研究假設驗證</strong></h3>

<p>本研究的主要發現支持了我們的研究假設 H1 和 H2。MWM 學習曲線的結果（圖 4-1）顯示，Pro-H 組從訓練中期（第 3 天）開始即表現出優於對照組的學習效率，表明高劑量益生菌介入可能加速了小鼠對空間線索的獲取和認知地圖的建立。更重要的是，探測試驗（圖 4-2）的結果證實了這種學習效果轉化為了更穩固的長期記憶，Pro-H 組展現了更強的記憶提取能力和搜索偏好性。</p>

<p>值得注意的是，低劑量組 (Pro-L, $1 \\times 10^8$ CFU/day) 在所有行為學指標上均未顯示出與對照組的顯著差異。這揭示了 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合對認知功能的影響具有明顯的<strong>劑量依賴性</strong>。這也解釋了文獻探討中部分研究（如 Wang et al., 2023）未觀察到顯著效應的原因，可能與其使用的劑量未達到有效閾值有關。</p>

<h3 id="52結果與文獻的對比及機制探討"><strong>5.2 結果與文獻的對比及機制探討</strong></h3>

<p>本研究的結果與先前在病理模型（如 AD 或壓力模型）中觀察到的益生菌改善認知功能的結論一致 (Bonfili et al., 2017; Messaoudi et al., 2011)，並將其擴展到了健康狀態下的「認知增強」效應。本研究的獨特之處在於揭示了 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 這一特定組合在健康小鼠中的作用。</p>

<p>我們進一步的機制探討（研究假設 H3）提供了支持腸-腦軸線調節認知功能的證據。</p>

<h4 id="521益生菌bdnf與神經可塑性"><strong>5.2.1 益生菌、BDNF 與神經可塑性</strong></h4>

<p>本研究發現 Pro-H 組海馬迴 BDNF 水平顯著高於對照組（圖 4-3A）。BDNF 是海馬迴依賴性學習與記憶（尤其是 MWM 任務）中突觸可塑性 (LTP) 的核心調節因子 (Poo, 2001)。BDNF 水平的升高意味著更強的神經可塑性潛力，這完美地解釋了 Pro-H 組在 MWM 學習和記憶測試中的優異表現。</p>

<p>益生菌如何提升海馬迴 BDNF？腸-腦軸線提供了可能的途徑。<em>Bifidobacterium</em> 和 <em>Lactobacillus</em> 菌株被證實是短鏈脂肪酸（SCFAs）的主要生產者，特別是丁酸鹽 (Dalile et al., 2019)。丁酸鹽作為一種組蛋白去乙醯酶（HDAC）抑制劑，已被證實能穿過血腦屏障，調節海馬迴中 BDNF 基因的表觀遺傳學表達，從而促進其轉錄 (Govindarajan et al., 2011)。雖然本研究未直接測量 SCFAs，但 Pro-H 組 BDNF 的顯著升高，強烈暗示了這條「菌群-代謝物-BDNF」通路的激活。</p>

<h4 id="522益生菌神經炎症與認知"><strong>5.2.2 益生菌、神經炎症與認知</strong></h4>

<p>海馬迴是極易受發炎因子影響的腦區。神經炎症，特別是 TNF-$\\alpha$ 等促炎因子的過度表達，會直接損害突觸可塑性 (LTP) 並抑制神經發生，從而導致認知功能下降 (Ma et al., 2019)。本研究發現 Pro-H 組的海馬迴 TNF-$\\alpha$ 水平顯著低於對照組（圖 4-3B）。</p>

<p><em>L. acidophilus</em> 和 <em>B. bifidum</em> 均被報導具有強大的免疫調節和腸道屏障保護功能 (Pinto-Sanchez et al., 2017)。透過改善腸道屏障的完整性，益生菌能有效減少 LPS 等內毒素從腸道滲漏至血液循環，從而降低全身性的低度發炎，並間接抑制中樞神經系統的「鏡像發炎反應」（mirror inflammatory response）。Pro-H 組中 TNF-$\\alpha$ 的降低，表明益生菌介入可能為海馬迴創造了一個更有利於學習和記憶的「低發炎」微環境。</p>

<p>有趣的是，本研究中 IL-6 的水平在各組間沒有顯著差異。這可能表明 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合的抗炎作用具有一定的選擇性，主要針對 TNF-$\\alpha$ 信號通路，而非 IL-6 通路；或者在健康狀態下，基礎 IL-6 水平本已較低，不易被進一步調降。</p>

<h3 id="53研究的優勢限制與未來方向"><strong>5.3 研究的優勢、限制與未來方向</strong></h3>

<h4 id="531研究優勢"><strong>5.3.1 研究優勢</strong></h4>

<p>本研究具有幾個明顯的優勢：(1) <strong>嚴謹的 MWM 範式：</strong> 我們不僅評估了學習曲線，還進行了探測試驗和可見平台測試，確保了結果的可靠性；(2) <strong>劑量效應探索：</strong> 設置高、低兩種劑量，明確了該菌株組合的有效劑量範圍；(3) <strong>健康動物模型：</strong> 證實了益生菌在非病理狀態下的認知「增強」潛力，這比病理「修復」更具保健應用意義。</p>

<h4 id="532研究限制"><strong>5.3.2 研究限制</strong></h4>

<p>儘管結果令人鼓舞，本研究仍存在以下限制：</p>

<ol>
<li><strong>機制探討的深度：</strong> 本研究僅檢測了 BDNF 和發炎因子作為「結果」指標。腸-腦軸線的「過程」指標，如腸道菌群結構的改變、腸道屏障完整性（如 Zonulin, Occludin）以及血液中 SCFAs 或 LPS 的水平並未檢測。</li>
<li><strong>單一性別：</strong> 本研究僅使用了雄性小鼠。鑑於腸道菌群和認知功能均存在性別二態性（Sex dimorphism），研究結果是否能推廣至雌性小鼠尚不清楚。</li>
<li><strong>菌株定殖分析：</strong> 本研究未分析外源補充的 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 是否成功且持久地定殖於小鼠腸道，或是僅為暫時過境但發揮了代謝調節作用。</li>
</ol>

<h4 id="533未來研究方向"><strong>5.3.3 未來研究方向</strong></h4>

<p>基於上述限制，未來的研究可從以下方向深入：</p>

<ol>
<li><strong>機制驗證：</strong> 應納入 16S rRNA 測序和代謝體學分析，明確益生菌介入如何重塑腸道菌群結構及 SCFAs 等關鍵代謝物的變化。</li>
<li><strong>性別差異：</strong> 應納入雌性小鼠進行平行實驗，比較益生菌對不同性別認知功能的影響差異。</li>
<li><strong>長期效應與停藥觀察：</strong> 應探討停止補充益生菌後，已獲得的認知提升效應能持續多久，以評估其應用的可持續性。</li>
<li><strong>轉化研究：</strong> 雖然動物實驗提供了有力證據，但最終仍需設計嚴謹的人體隨機對照試驗（RCT），以驗證此菌株組合在人類（特別是健康或輕度認知障礙群體）中的有效性。</li>
</ol>

<hr/>

<h2 id="第六章結論conclusion"><strong>第六章 結論 (Conclusion)</strong></h2>

<p>本研究系統性地評估了嗜酸乳桿菌 (<em>L. acidophilus</em>) 與雙歧桿菌 (<em>B. bifidum</em>) 組合對健康 C57BL/6J 雄性小鼠空間學習與記憶的影響。研究結論如下：</p>

<ol>
<li>連續 6 週補充高劑量（$1 \\times 10^9$ CFU/day）的 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合，能顯著提升健康小鼠在莫里斯水迷宮中的空間學習效率和空間記憶鞏固能力。</li>
<li>此益生菌組合對認知功能的改善效應具有劑量依賴性，低劑量（$1 \\times 10^8$ CFU/day）組未觀察到顯著效果。</li>
<li>其潛在作用機制可能涉及腸-腦軸線的調節，表現為顯著提升海馬迴中 BDNF 的水平（增強神經可塑性）並顯著降低促炎因子 TNF-$\\alpha$ 的水平（抑制神經炎症）。</li>
</ol>

<p>本研究為 <em>L. acidophilus</em> 與 <em>B. bifidum</em> 組合作為新型「精神益生菌」或認知功能增強劑提供了重要的臨床前實驗證據，對未來功能性食品或保健品的開發具有參考價值。</p>

<hr/>

<h2 id="第七章參考文獻references"><strong>第七章 參考文獻 (References)</strong></h2>

<p><strong>\[注意：以下為模擬與真實文獻的混合列表，旨在展示 APA 格式範例\]</strong></p>

<ul>
<li>Bird, C. M., &amp; Burgess, N. (2008). The hippocampus and spatial memory: Findings and future directions. <em>Nature Reviews Neuroscience, 9</em>(3), 182-194.</li>
<li>Bliss, T. V., &amp; Lømo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. <em>The Journal of Physiology, 232</em>(2), 331-356.</li>
<li>Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., ... &amp; Eleuteri, A. M. (2017). Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. <em>Scientific Reports, 7</em>(1), 2426\.</li>
<li>Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., ... &amp; Cryan, J. F. (2011). Ingestion of <em>Lactobacillus</em> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. <em>Proceedings of the National Academy of Sciences, 108</em>(38), 16050-16055.</li>
<li>Cryan, J. F., O'Riordan, K. J., Cowan, C. S., Sandhu, K. V., Bastiaanssen, T. F., Boehme, M., ... &amp; Dinan, T. G. (2019). The microbiota-gut-brain axis. <em>Physiological Reviews, 99</em>(4), 1877-2013.</li>
<li>Dalile, B., Van Oudenhove, L., Vervliet, B., &amp; Verbeke, K. (2019). The role of short-chain fatty acids in microbiota–gut–brain communication. <em>Nature Reviews Gastroenterology &amp; Hepatology, 16</em>(8), 461-478.</li>
<li>Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., &amp; Dinan, T. G. (2010). Effects of the probiotic <em>Bifidobacterium infantis</em> in the maternal separation model of depression. <em>Neuroscience, 170</em>(4), 1179-1188.</li>
<li>Dinan, T. G., Stanton, C., &amp; Cryan, J. F. (2013). Psychobiotics: a novel class of psychotropic. <em>Biological Psychiatry, 74</em>(10), 720-726.</li>
<li>Govindarajan, N., Agis-Balboa, R. C., Walter, J., Sananbenesi, F., &amp; Fischer, A. (2011). Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. <em>Journal of Alzheimer's Disease, 26</em>(1), 187-197.</li>
<li>Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., ... &amp; Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. <em>Nature Reviews Gastroenterology &amp; Hepatology, 11</em>(8), 506-514.</li>
<li>Ma, Q., Chen, S., Wang, T., Zhang, X., &amp; Wang, R. (2019). Neuroinflammation in the hippocampus of type 2 diabetic mice: The role of the gut microbiota. <em>Brain, Behavior, and Immunity, 80</em>, 681-693.</li>
<li>Mayer, E. A., Nance, K., &amp; Chen, S. (2022). The gut-brain axis. <em>Annual Review of Medicine, 73</em>, 439-453.</li>
<li>Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., ... &amp; Cazaubiel, J. M. (2011). Assessment of psychotropic-like properties of a probiotic formulation (<em>Lactobacillus helveticus</em> R0052 and <em>Bifidobacterium longum</em> R0175) in rats and human subjects. <em>British Journal of Nutrition, 105</em>(5), 755-764.</li>
<li>Morris, R. G. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. <em>Journal of Neuroscience Methods, 11</em>(1), 47-60.</li>
<li>O'Keefe, J., &amp; Nadel, L. (1978). <em>The Hippocampus as a Cognitive Map</em>. Oxford University Press.</li>
<li>Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., ... &amp; Bercik, P. (2017). Probiotic <em>Bifidobacterium longum</em> NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. <em>Gastroenterology, 153</em>(2), 448-459.</li>
<li>Poo, M. M. (2001). Neurotrophins as synaptic modulators. <em>Nature Reviews Neuroscience, 2</em>(1), 24-32.</li>
<li>\[模擬文獻\] Smith, A. B., et al. (2022). <em>Lactobacillus acidophilus</em> NCFM supplementation improves learning in healthy mice and modulates hippocampal BDNF. <em>Journal of Neuroinflammation, 19</em>(1), 112\.</li>
<li>Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., ... &amp; Zetterberg, H. (2017). Gut microbiome alterations in Alzheimer's disease. <em>Scientific Reports, 7</em>(1), 13537\.</li>
<li>\[模擬文獻\] Wang, L., et al. (2023). Limited impact of <em>Bifidobacterium animalis</em> subsp. <em>lactis</em> BB-12 on cognitive performance in healthy C57BL/6J mice. <em>Behavioural Brain Research, 440</em>, 114250\.</li>
<li>Wang, T., Hu, X., Wang, J., Zhao, J., Zhang, H., &amp; Chen, W. (2019). <em>Lactobacillus acidophilus</em> CUL60 modulates the kynurenine pathway and impacts cognitive function in a mouse model. <em>Brain, Behavior, and Immunity, 80</em>, 209-220.</li>
</ul>

<hr/>

<hr/>

<hr/>

<h2 id="effectsofprobioticsupplementationlactobacillusacidophilusandbifidobacteriumbifidumonspatiallearningandmemoryinmiceevidencefromthemorriswatermaze">**Effects of Probiotic Supplementation (<em>Lactobacillus acidophilus</em> and <em>Bifidobacterium bifidum</em>) on Spatial Learning and Memory in Mice: Evidence from the Morris Water Maze**</h2>

<p><strong>Abstract</strong></p>

<p>In recent years, the "Gut-Brain Axis" has emerged as a focal area in neuroscience, demonstrating that the gut microbiota can influence host cognitive functions and emotional states through multiple pathways. Among these, specific probiotic strains (termed "Psychobiotics") have garnered attention for their potential to enhance learning and memory. This study aimed to investigate the effects of a specific probiotic combination—<em>Lactobacillus acidophilus</em> and <em>Bifidobacterium bifidum</em>—on spatial learning and memory in healthy C57BL/6J male mice, and to preliminarily explore the underlying neurobiological mechanisms.</p>

<p>Thirty 8-week-old male C57BL/6J mice were randomly divided into three groups: Control (Vehicle, n=10), Low-dose Probiotics (Pro-L, $1 \\times 10^8$ CFU/day, n=10), and High-dose Probiotics (Pro-H, $1 \\times 10^9$ CFU/day, n=10). The probiotic groups received a 1:1 mixture of <em>L. acidophilus</em> and <em>B. bifidum</em> suspension daily via oral gavage, while the control group received an equal volume of saline for 6 consecutive weeks. Following the intervention, the Morris Water Maze (MWM) test, consisting of a 5-day acquisition phase and a 1-day probe trial, was conducted to assess spatial learning and memory. After the behavioral tests, hippocampal tissues were collected to measure levels of Brain-Derived Neurotrophic Factor (BDNF) and inflammatory cytokines (TNF-$\\alpha$, IL-6) using ELISA.</p>

<p>Results from the MWM acquisition phase showed that escape latency significantly decreased across all groups over the training days. However, starting from Day 3, the escape latency of the Pro-H group was significantly shorter than that of the control group ($p \&lt; 0.05$). In the probe trial on Day 6, the Pro-H group spent significantly more time in the target quadrant ($p \&lt; 0.01$) and exhibited a higher number of platform crossings ($p \&lt; 0.05$) compared to the control group. No significant differences were observed in the Pro-L group. Mechanism analysis revealed that the hippocampal BDNF level in the Pro-H group was significantly higher ($p \&lt; 0.05$), while the pro-inflammatory cytokine TNF-$\\alpha$ level was significantly lower ($p \&lt; 0.05$), compared to the control group.</p>

<p>This study demonstrates that high-dose supplementation with a specific combination of <em>Lactobacillus acidophilus</em> and <em>Bifidobacterium bifidum</em> significantly enhances spatial learning efficiency and memory consolidation in healthy mice. This effect may be associated with its ability to enhance hippocampal neuroplasticity (elevated BDNF) and reduce neuroinflammation (suppressed TNF-$\\alpha$). This research provides experimental evidence supporting the use of specific probiotic combinations as cognitive enhancers.</p>

<p><strong>Keywords:</strong> <em>Lactobacillus acidophilus</em>, <em>Bifidobacterium bifidum</em>, Morris Water Maze (MWM), Spatial Learning and Memory, Gut-Brain Axis, Brain-Derived Neurotrophic Factor (BDNF)</p>

<hr/>

<h2 id="chapter1introduction"><strong>Chapter 1\. Introduction</strong></h2>

<h3 id="11backgroundandrationale"><strong>1.1 Background and Rationale</strong></h3>

<p>The brain and the gut, two seemingly disparate organs, have been confirmed in recent years to possess a complex and dynamic bidirectional communication network known as the "Gut-Brain Axis" (Cryan et al., 2019). This system integrates multiple neural, endocrine, immune, and metabolic pathways, enabling the gut microbiota to profoundly influence the host's central nervous system (CNS) functions, including emotional regulation, stress responses, and even higher cognitive functions such as learning and memory (Mayer et al., 2022).</p>

<p>Gut microbiota dysbiosis has been found to be closely associated with the pathological processes of various neurological disorders, such as depression, anxiety, Parkinson's disease, and Alzheimer's disease (AD) (Vogt et al., 2017). Conversely, strategies aimed at improving CNS function by modulating the gut microbiota have emerged as a new direction in translational medicine. Among these, "probiotics," particularly strains confirmed to be beneficial for mental health (termed "psychobiotics"), are receiving increasing attention (Dinan et al., 2013).</p>

<p>Among the many probiotics, <em>Lactobacillus</em> and <em>Bifidobacterium</em> are the two most extensively studied genera. <em>Lactobacillus</em> strains have been reported to modulate levels of the neurotransmitter GABA, while <em>Bifidobacterium</em> strains have been found to influence serotonin production and possess anti-inflammatory properties (Bravo et al., 2011; Desbonnet et al., 2010). Animal studies have shown that supplementation with specific <em>Lactobacillus</em> or <em>Bifidobacterium</em> strains can ameliorate cognitive deficits in mouse models of stress or disease (e.g., AD models) (Bonfili et al., 2017). However, these studies primarily focus on the "restorative" effects in pathological states. Research on whether they have a cognitive "enhancing" effect in healthy individuals remains relatively limited and inconclusive.</p>

<p>Furthermore, the effects of probiotics are highly "strain-specific" and "dose-dependent," and combinations of different strains may produce synergistic effects. <em>Lactobacillus acidophilus</em> and <em>Bifidobacterium bifidum</em> are dominant species in the gut, both playing important roles in maintaining intestinal barrier integrity and immune modulation. Investigating the impact of this specific two-strain combination on the cognitive function of healthy mice is significant for the development of novel cognitive health supplements.</p>

<h3 id="12researchobjectives"><strong>1.2 Research Objectives</strong></h3>

<p>The assessment of learning and memory, especially spatial learning, is a classic topic in neuroscience. Spatial learning and memory are highly dependent on the function of the hippocampus (O'Keefe &amp; Nadel, 1978). The Morris Water Maze (MWM) test is the gold standard for assessing hippocampus-dependent spatial learning and memory in rodents (Morris, 1984). It allows for the precise quantification of the animal's learning curve (acquisition) and long-term memory consolidation.</p>

<p>Therefore, this study aims to use the MWM test to systematically evaluate the effects of supplementation with a specific probiotic combination—<em>L. acidophilus</em> and <em>B. bifidum</em>—on the spatial learning and memory capabilities of healthy C57BL/6J mice.</p>

<p>The specific objectives are:</p>

<ol>
<li>To investigate whether 6 weeks of supplementation with an <em>L. acidophilus</em> and <em>B. bifidum</em> combination can improve <strong>spatial learning efficiency</strong> (i.e., shorten escape latency) in the MWM in healthy mice.</li>
<li>To assess whether this probiotic combination can enhance <strong>spatial memory consolidation</strong> (i.e., increase the time spent in the target quadrant during the MWM probe trial) in healthy mice.</li>
<li>To explore the effects of the probiotic intervention on the levels of the key neuroplasticity molecule <strong>Brain-Derived Neurotrophic Factor (BDNF)</strong> and <strong>neuroinflammatory factors (TNF-$\\alpha$, IL-6)</strong> in the hippocampus, providing a preliminary exploration of the potential mechanisms.</li>
</ol>

<h3 id="13researchhypotheses"><strong>1.3 Research Hypotheses</strong></h3>

<p>Based on the background and objectives, this study proposes the following hypotheses:</p>

<ul>
<li><strong>H1:</strong> Compared to the control group, mice in the probiotic group supplemented with the <em>L. acidophilus</em> and <em>B. bifidum</em> combination will exhibit shorter escape latencies during the MWM acquisition phase.</li>
<li><strong>H2:</strong> In the MWM probe trial, the probiotic group mice will spend significantly more time in the target quadrant than the control group.</li>
<li><strong>H3:</strong> Probiotic supplementation will significantly increase the expression of BDNF and decrease the levels of TNF-$\\alpha$ and IL-6 in the mouse hippocampus, with this effect being more pronounced in the high-dose group.</li>
</ul>

<p>The findings of this study will help elucidate the role of specific probiotic combinations in modulating the gut-brain axis and promoting cognitive function in healthy individuals, providing a scientific basis for the development of related health products.</p>

<hr/>

<h2 id="chapter2literaturereview"><strong>Chapter 2\. Literature Review</strong></h2>

<p>This chapter aims to establish the theoretical foundation of the study by systematically reviewing the biological basis of spatial learning and memory, the application of the MWM methodology, the core concepts of the gut-brain axis, and relevant empirical research on the impact of probiotics on cognitive function. Finally, it will define the academic positioning and research gap of this study.</p>

<h3 id="21thebiologicalbasisofspatiallearningandmemory"><strong>2.1 The Biological Basis of Spatial Learning and Memory</strong></h3>

<p>Learning and memory are among the highest functions of the central nervous system. Memory can be classified into various types based on the nature and duration of the information. Spatial learning and memory, a form of declarative memory, specifically refers to the ability of an individual to acquire, store, and recall the relative positions of objects and navigational routes within an environment (Bird &amp; Burgess, 2008).</p>

<h4 id="211molecularmechanismsoflearningandthehippocampus"><strong>2.1.1 Molecular Mechanisms of Learning and the Hippocampus</strong></h4>

<p>At the molecular level, the formation of learning and memory is believed to be the result of synaptic plasticity—changes in the strength of connections between neurons. Among these, "Long-Term Potentiation" (LTP) is currently recognized as one of the most critical mechanisms (Bliss &amp; Lømo, 1973). LTP refers to a persistent strengthening of synaptic responses following high-frequency stimulation, a process involving the activation of NMDA receptors, calcium influx, and the subsequent activation of protein kinases (like CaMKII), ultimately leading to an increased number or enhanced function of AMPA receptors.</p>

<h4 id="212theroleofbrain-derivedneurotrophicfactorbdnf"><strong>2.1.2 The Role of Brain-Derived Neurotrophic Factor (BDNF)</strong></h4>

<p>Brain-Derived Neurotrophic Factor (BDNF) plays a crucial role in maintaining LTP and synaptic plasticity. BDNF is a neurotrophic protein highly expressed in the adult brain, especially in the hippocampus and cortex. BDNF not only promotes the survival, differentiation, and growth of neurons but also directly participates in synaptic maturation and functional regulation (Poo, 2001). Studies have shown that elevated BDNF levels are closely correlated with enhanced learning and memory, whereas decreased BDNF levels are associated with cognitive decline in various neurodegenerative diseases.</p>

<h4 id="213thehippocampusthecorebrainregionforspatiallearning"><strong>2.1.3 The Hippocampus: The Core Brain Region for Spatial Learning</strong></h4>

<p>The hippocampus is widely recognized as the key brain region for spatial learning and memory. The "Cognitive Map" theory proposed by O'Keefe and Nadel (1978) suggests that "place cells" within the hippocampus are responsible for encoding the animal's specific location in an environment, thereby constructing an internal spatial map. These cells fire selectively as the animal navigates. Damage to the hippocampus results in severe spatial navigation deficits, which has been confirmed in both animal models and human patients.</p>

<h3 id="22themorriswatermazemwmmethodology"><strong>2.2 The Morris Water Maze (MWM) Methodology</strong></h3>

<p>To effectively assess hippocampus-dependent spatial learning and memory, Richard Morris designed the MWM test in 1984\. This method quickly became the gold standard in behavioral neuroscience because it effectively eliminates olfactory cues and relies on a relatively constant motivation (escape from water) (Morris, 1984).</p>

<p>The MWM typically involves a circular pool filled with opaque water, concealing a platform just below the water surface. Fixed, distant visual cues (extra-maze cues) are placed around the pool.</p>

<ol>
<li><strong>Acquisition Phase (Training):</strong> The animal is placed into the water from different quadrants and must use the extra-maze cues to locate and swim to the hidden platform. As training progresses, the time (Escape Latency) and distance swum to find the platform gradually decrease, reflecting the spatial learning curve.</li>
<li><strong>Probe Trial (Retention Test):</strong> After training, the platform is removed. The animal is allowed to swim freely for a set time (e.g., 60 seconds). Researchers record the percentage of time spent in the original platform quadrant (target quadrant) and the number of crossings over the original platform location. These metrics reflect the consolidation and precision of spatial memory.</li>
</ol>

<p>The advantage of the MWM is its ability to clearly distinguish between the learning process and memory retrieval, making it an ideal tool for evaluating the efficacy of potential cognitive enhancers, such as probiotics.</p>

<h3 id="23probioticsandtheirroleinthegut-brainaxis"><strong>2.3 Probiotics and Their Role in the Gut-Brain Axis</strong></h3>

<h4 id="231definitionsofprobioticsandpsychobiotics"><strong>2.3.1 Definitions of Probiotics and Psychobiotics</strong></h4>

<p>Probiotics are defined as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host" (Hill et al., 2014). "Psychobiotics" specifically refer to those probiotics that produce mental health benefits for the host and influence the gut-brain axis (Dinan et al., 2013).</p>

<h4 id="232bidirectionalcommunicationpathwaysofthegut-brainaxis"><strong>2.3.2 Bidirectional Communication Pathways of the Gut-Brain Axis</strong></h4>

<p>The gut microbiota communicates with the brain via multiple bidirectional pathways, which collectively form the gut-brain axis:</p>

<ol>
<li><strong>Neural Pathway:</strong> Primarily through the Vagus Nerve. Bacterial metabolites or cell wall components in the gut can stimulate enteric sensory neurons, with signals transmitted to the CNS via the vagus nerve (Bravo et al., 2011).</li>
<li><strong>Immune Pathway:</strong> The gut microbiota is a major regulator of the host immune system. Dysbiosis can lead to compromised intestinal barrier (leaky gut), allowing endotoxins like bacterial lipopolysaccharide (LPS) to enter the bloodstream, triggering systemic low-grade inflammation. This can further lead to neuroinflammation, impairing hippocampal function (Ma et al., 2019).</li>
<li><strong>Endocrine/Metabolic Pathway:</strong> The gut microbiota can synthesize or regulate various neuroactive substances. For instance, some bacteria produce Short-Chain Fatty Acids (SCFAs), such as butyrate. SCFAs not only serve as an energy source for colonocytes but can also cross the blood-brain barrier and regulate BDNF expression in the hippocampus (Dalile et al., 2019). Furthermore, the gut microbiota participates in tryptophan metabolism, influencing the synthesis of serotonin in the CNS.</li>
</ol>

<h4 id="233characteristicsoflacidophilusandbbifidum">**2.3.3 Characteristics of <em>L. acidophilus</em> and *B. bifidum***</h4>

<ul>
<li><strong>Lactobacillus acidophilus:</strong> As one of the most well-known lactobacilli, <em>L. acidophilus</em> is noted for its strong gut colonization ability and immunomodulatory effects. Studies have found that specific <em>L. acidophilus</em> strains can modulate the kynurenine pathway, reducing the production of neurotoxic metabolites, and may exert anxiolytic effects by influencing GABA receptor expression (Wang et al., 2019).</li>
<li><strong>Bifidobacterium bifidum:</strong> <em>Bifidobacterium</em> is a dominant genus in the infant gut and is associated with early neurodevelopment. <em>B. bifidum</em> strains have been shown to possess potent anti-inflammatory properties, inhibiting the production of pro-inflammatory cytokines (like TNF-$\\alpha$, IL-6) and repairing compromised intestinal barriers (Pinto-Sanchez et al., 2017).</li>
</ul>

<h3 id="24empiricalstudiesonprobioticsupplementationandcognition"><strong>2.4 Empirical Studies on Probiotic Supplementation and Cognition</strong></h3>

<p>In recent years, a growing number of animal studies have begun to explore the impact of probiotics on cognitive function.</p>

<ul>
<li><strong>In Pathological Models:</strong> Many studies focus on Alzheimer's disease (AD) or aging animal models. For example, Bonfili et al. (2017) found that administering a probiotic consortium (SLAB51) containing <em>Lactobacillus</em> and <em>Bifidobacterium</em> to 3xTg-AD mice significantly improved their MWM performance and reduced A$\\beta$ plaque deposition in the hippocampus.</li>
<li><strong>In Stress Models:</strong> Stress is a common factor leading to cognitive decline. Research shows that supplementing with a combination of <em>L. helveticus</em> and <em>B. longum</em> reduced anxiety-like behaviors and improved spatial memory deficits in chronically stressed rats (Messaoudi et al., 2011).</li>
<li><strong>In Healthy Animals:</strong> Studies on the cognitive "enhancing" effects of probiotics in healthy animals are relatively scarce. A study by Smith et al. (2022) (a <em>simulated</em> reference) indicated that administering the <em>L. acidophilus</em> NCFM strain to healthy C57BL/6J mice resulted in a slight improvement in the MWM learning curve, accompanied by an upregulation of hippocampal BDNF. However, a study by Wang et al. (2023) (a <em>simulated</em> reference) using a different <em>Bifidobacterium</em> strain did not observe significant differences in MWM performance in healthy mice.</li>
</ul>

<h3 id="25researchgapandstudypositioning"><strong>2.5 Research Gap and Study Positioning</strong></h3>

<p>A review of the existing literature reveals several clear research gaps:</p>

<ol>
<li><strong>Synergistic Effects of Strain Combinations:</strong> Most research focuses on single strains or complex multi-strain formulas. The effect of the specific, complementary combination of <em>L. acidophilus</em> and <em>B. bifidum</em> on spatial memory in healthy individuals remains unclear.</li>
<li><strong>Dose-Response Relationship:</strong> Probiotic dosages used in existing studies vary widely (from $10^7$ to $10^{10}$ CFU/day). There is a lack of systematic investigation into the dose-response relationship for the <em>L. acidophilus</em> and <em>B. bifidum</em> combination.</li>
<li><strong>Enhancement in Healthy States:</strong> As mentioned, compared to pathological restoration, the cognitive "enhancement" effect of probiotics in a healthy state requires more direct and reliable evidence, especially assessments using the gold-standard MWM.</li>
</ol>

<p>Therefore, this study is positioned to fill these gaps. We selected the specific combination of <em>L. acidophilus</em> and <em>B. bifidum</em>, employed two different doses (low dose $10^8$ CFU/day, high dose $10^9$ CFU/day), and used healthy C57BL/6J mice as subjects. Utilizing a rigorous MWM experimental paradigm, we aim to precisely evaluate the potential cognitive-enhancing effects of this probiotic combination in a non-pathological state and explore its possible mechanisms.</p>

<hr/>

<h2 id="chapter3materialsandmethods"><strong>Chapter 3\. Materials and Methods</strong></h2>

<p>All experimental procedures in this study strictly adhered to animal welfare regulations and were approved by the Institutional Animal Care and Use Committee (IACUC) of \[Name of Your Institution\] (Approval No: \[Simulated No. IACUC-202X-XXX\]).</p>

<h3 id="31experimentalanimals"><strong>3.1 Experimental Animals</strong></h3>

<h4 id="311animalstrainnumberandhousing"><strong>3.1.1 Animal Strain, Number, and Housing</strong></h4>

<p>This study used 30 male C57BL/6J mice (8 weeks old), purchased from \[Simulated Animal Center Name\]. The C57BL/6J strain is widely used due to its stable genetic background and consistent performance in behavioral tests like the MWM.</p>

<p>All mice were housed in a Specific Pathogen-Free (SPF) grade animal facility under controlled environmental conditions: temperature $22 \\pm 2^\\circ\\text{C}$, relative humidity $55 \\pm 10\\%$, and a 12-hour light/12-hour dark cycle (lights on at 8:00 AM). Mice were group-housed (5 per cage) with <em>ad libitum</em> access to standard chow pellets and sterile water. All animals underwent a 1-week acclimatization period before the experiment began.</p>

<h4 id="312groupingandrandomization"><strong>3.1.2 Grouping and Randomization</strong></h4>

<p>The 30 mice were randomly divided into three groups (n=10 per group) based on body weight using a random number table:</p>

<ol>
<li><strong>Control Group (Vehicle, CON):</strong> Administered an equal volume of physiological saline.</li>
<li><strong>Low-dose Probiotic Group (Pro-L):</strong> Administered $1 \\times 10^8$ CFU/day of probiotic suspension.</li>
<li><strong>High-dose Probiotic Group (Pro-H):</strong> Administered $1 \\times 10^9$ CFU/day of probiotic suspension.</li>
</ol>

<h3 id="32probioticpreparationandadministration"><strong>3.2 Probiotic Preparation and Administration</strong></h3>

<h4 id="321strainsourceandpreparation"><strong>3.2.1 Strain Source and Preparation</strong></h4>

<p>Lyophilized powders of <em>Lactobacillus acidophilus</em> \[Strain No., e.g., ATCC 4356\] and <em>Bifidobacterium bifidum</em> \[Strain No., e.g., ATCC 29521\] were purchased from \[Simulated Culture Collection or Company\].</p>

<p>Prior to the experiment, the lyophilized powders of the two strains were mixed at a 1:1 ratio (by CFU count) and resuspended in sterile physiological saline (0.9% NaCl). The suspension was freshly prepared daily before administration, and the concentration and viability of the strains were confirmed using the plate count method. The prepared suspensions were divided into two concentrations: low dose ($1 \\times 10^9$ CFU/mL) and high dose ($1 \\times 10^{10}$ CFU/mL).</p>

<h4 id="322dosageandadministration"><strong>3.2.2 Dosage and Administration</strong></h4>

<p>Starting from the 9th week of age, oral gavage was performed daily between 9:00 AM and 10:00 AM.</p>

<ul>
<li>Mice in the Pro-L and Pro-H groups received 0.1 mL of the low-dose and high-dose bacterial solutions, respectively, ensuring a total daily intake of $1 \\times 10^8$ CFU and $1 \\times 10^9$ CFU.</li>
<li>Mice in the CON group received 0.1 mL of physiological saline as a vehicle control.</li>
</ul>

<p>This intervention lasted for 6 weeks (42 days). Throughout the intervention, mouse body weight was recorded weekly, and their health status was monitored.</p>

<h3 id="33morriswatermazemwmtest"><strong>3.3 Morris Water Maze (MWM) Test</strong></h3>

<p>The MWM test commenced after 6 weeks of probiotic intervention. The experiment was conducted in a dedicated, quiet behavioral testing room.</p>

<h4 id="331apparatusandenvironment"><strong>3.3.1 Apparatus and Environment</strong></h4>

<p>The MWM apparatus was a white circular pool (120 cm in diameter, 50 cm in height). The pool was filled with water to a depth of 30 cm, and the water temperature was maintained at $22 \\pm 1^\\circ\\text{C}$. Non-toxic white food coloring was added to the water to make it opaque, thereby hiding the platform.  </p>
<p>The hidden platform was a white circular platform (10 cm in diameter), placed in the center of a specific quadrant (the target quadrant, e.g., NE), with its top submerged 1.5 cm below the water surface.  </p>
<p>Four distinct geometric shapes and colors were hung on the walls surrounding the pool as extra-maze cues, and their positions remained unchanged throughout the experiment.  </p>
<p>A camera was mounted directly above the pool, connected to a video-tracking system \[Simulated Software Name, e.g., Any-maze or EthoVision XT\] to automatically record swimming paths, speed, latency, and other parameters.</p>

<h4 id="332experimentalprocedureandmetrics"><strong>3.3.2 Experimental Procedure and Metrics</strong></h4>

<p>The MWM test was conducted over 6 days.</p>

<ul>
<li><strong>A. Acquisition Phase (Day 1 \- Day 5):</strong></li>
<li>Four training trials were conducted per day, with an inter-trial interval of approximately 15 minutes.</li>
<li>The starting points for the 4 trials were located at the edge of the four quadrants (excluding the target) in a randomized order.</li>
<li>At the start of each trial, the mouse was gently placed into the water facing the pool wall. The mouse had 60 seconds to find the hidden platform.</li>
<li>If the mouse found the platform within 60 seconds, it was allowed to stay on it for 15 seconds to memorize the spatial cues. If it failed to find the platform within 60 seconds, it was gently guided to the platform by the experimenter and kept there for 15 seconds.</li>
<li>Metrics recorded: <strong>Escape Latency</strong> (time to find the platform) and <strong>Path Length</strong>.</li>
<li><strong>B. Probe Trial (Day 6):</strong></li>
<li>Conducted 24 hours after the final training session on Day 5\.</li>
<li>The platform was removed from the pool.</li>
<li>The mouse was released from the quadrant farthest from the target (e.g., SW) and allowed to swim freely for 60 seconds.</li>
<li>Metrics recorded: <strong>Time in Target Quadrant (%)</strong> and <strong>Platform Crossings</strong> (number of times crossing the original platform location).</li>
<li><strong>C. Visible Platform Test (After Probe Trial on Day 6):</strong></li>
<li>To rule out the effects of probiotics on vision, motor ability, or motivation to swim.</li>
<li>A conspicuous marker (e.g., a small red flag) was placed on the platform, and the platform was raised 1 cm above the water surface, making it clearly visible.</li>
<li>Mice were placed in the water, and the time to find the visible platform was recorded. No significant difference between groups would exclude these confounding factors.</li>
</ul>

<h3 id="34tissuesamplingandbiochemicalanalysis"><strong>3.4 Tissue Sampling and Biochemical Analysis</strong></h3>

<p>After the MWM test (Day 7), mice were anesthetized with CO2 and rapidly decapitated.  </p>
<p>Bilateral hippocampal tissues were immediately dissected on ice, weighed, snap-frozen in liquid nitrogen, and subsequently stored at $-80^\\circ\\text{C}$ for later analysis.</p>

<h4 id="341hippocampaltissuehomogenization"><strong>3.4.1 Hippocampal Tissue Homogenization</strong></h4>

<p>One side of the hippocampal tissue was homogenized on ice in RIPA buffer containing protease inhibitors. The homogenate was centrifuged at 12,000 rpm for 15 minutes at $4^\\circ\\text{C}$, and the supernatant was collected. The total protein concentration was determined using a BCA protein assay kit.</p>

<h4 id="342elisadetection"><strong>3.4.2 ELISA Detection</strong></h4>

<p>Commercially available ELISA kits (purchased from \[Simulated Vendor, e.g., R\&amp;D Systems or Abcam\]) were used to measure the levels of BDNF, TNF-$\\alpha$, and IL-6 in the hippocampal homogenate supernatant. All procedures were performed strictly according to the kit manufacturer's instructions. All samples were assayed in triplicate. Final concentrations were expressed as pg/mg of total protein.</p>

<h3 id="35statisticalanalysis"><strong>3.5 Statistical Analysis</strong></h3>

<p>All experimental data were statistically analyzed and graphed using GraphPad Prism 9.0 software. Data are presented as <strong>Mean $\\pm$ Standard Error of the Mean (SEM)</strong>.</p>

<ol>
<li><strong>MWM Learning Curve (Escape Latency):</strong> Analyzed using <strong>Two-way Repeated Measures (RM) ANOVA</strong>, with Group as the between-subjects factor and Day as the within-subjects factor. If a significant interaction was found, a Bonferroni post-hoc test was performed.</li>
<li><strong>MWM Probe Trial and Biochemical Indicators:</strong> Analyzed using <strong>One-way ANOVA</strong> for between-group comparisons. If the F-value reached significance, Tukey's HSD post-hoc test was used for multiple comparisons.</li>
<li><strong>Significance Level:</strong> The significance level ($p$-value) for all statistical tests was set at $\&lt; 0.05$.</li>
</ol>

<hr/>

<h2 id="chapter4results"><strong>Chapter 4\. Results</strong></h2>

<p>This chapter presents the performance of the mice in the MWM behavioral test and the biochemical analysis results of related neurotrophic and inflammatory factors in the hippocampus following 6 weeks of probiotic intervention.</p>

<h3 id="41effectofprobioticinterventionongeneralconditionofmice"><strong>4.1 Effect of Probiotic Intervention on General Condition of Mice</strong></h3>

<p>During the 6-week intervention period, all mice remained in good health with no obvious adverse reactions or behavioral abnormalities. Weekly weight monitoring showed no significant differences in the body-weight gain curves among the three groups (CON, Pro-L, Pro-H) (data not shown), indicating that the <em>L. acidophilus</em> and <em>B. bifidum</em> combination at the doses used in this study has good biological safety.</p>

<h3 id="42mwmvisualandmotivationaltestresults"><strong>4.2 MWM Visual and Motivational Test Results</strong></h3>

<p>After the MWM probe trial on Day 6, we conducted the visible platform test. The results showed no statistically significant differences among the three groups in escape latency to find the visible platform (CON: $10.2 \\pm 1.5$ s; Pro-L: $9.8 \\pm 1.2$ s; Pro-H: $9.5 \\pm 1.1$ s) or in swimming speed (One-way ANOVA, $F(2, 27\) \= 0.15, p \= 0.86$). This result rules out the possibility that the probiotic intervention interfered with the mice's vision, motor abilities, or motivation to escape, thereby ensuring the validity of the MWM spatial learning and memory results.</p>

<h3 id="43effectofprobioticsonmwmspatiallearningacquisitionphase"><strong>4.3 Effect of Probiotics on MWM Spatial Learning (Acquisition Phase)</strong></h3>

<p>Figure 4-1 shows the changes in escape latency for the three groups during the 5-day acquisition training.</p>

<p>**\[Figure 4-1: Learning curves of escape latency in the MWM acquisition phase for the three groups. Y-axis represents Escape Latency (seconds), X-axis represents Training Day (Day 1-5). Data are presented as Mean $\\pm$ SEM. \* $p \&lt; 0.05$ vs. CON group.\]**</p>

<p><strong>\[Simulated Figure Description\]</strong></p>

<ul>
<li><strong>Figure 4-1 Simulated Data &amp; Description:</strong></li>
<li><strong>Day 1:</strong> CON ($50.5 \\pm 2.5$s), Pro-L ($49.8 \\pm 3.0$s), Pro-H ($50.1 \\pm 2.8$s)</li>
<li><strong>Day 2:</strong> CON ($38.2 \\pm 2.1$s), Pro-L ($36.5 \\pm 2.5$s), Pro-H ($35.0 \\pm 2.2$s)</li>
<li><strong>Day 3:</strong> CON ($30.1 \\pm 1.8$s), Pro-L ($28.0 \\pm 2.0$s), Pro-H ($24.5 \\pm 1.5$s)\*</li>
<li><strong>Day 4:</strong> CON ($25.5 \\pm 1.5$s), Pro-L ($22.1 \\pm 1.6$s), Pro-H ($18.0 \\pm 1.2$s)\*</li>
<li><strong>Day 5:</strong> CON ($20.1 \\pm 1.2$s), Pro-L ($18.5 \\pm 1.4$s), Pro-H ($14.5 \\pm 1.0$s)\*</li>
</ul>

<p>Two-way RM ANOVA revealed a significant main effect of Day ($F(4, 108\) \= 85.2, p \&lt; 0.001$), indicating that mice in all groups showed a significant learning effect. There was also a significant main effect of Group ($F(2, 27\) \= 5.6, p \&lt; 0.01$).  </p>
<p>Importantly, there was a significant Time x Group interaction ($F(8, 108\) \= 2.8, p \&lt; 0.01$).  </p>
<p>Bonferroni post-hoc analysis showed no significant differences in escape latency among the three groups on Day 1 and Day 2\. However, starting from Day 3, the escape latency of the Pro-H group was significantly shorter than that of the CON group (Day 3, $p \&lt; 0.05$; Day 4, $p \&lt; 0.05$; Day 5, $p \&lt; 0.05$). The Pro-L group showed a trend towards shorter latency on Days 4 and 5, but it did not reach statistical significance compared to the CON group.  </p>
<p>This result indicates that high-dose probiotic supplementation significantly enhanced the spatial learning efficiency of healthy mice.</p>

<h3 id="44effectofprobioticsonmwmspatialmemoryprobetrial"><strong>4.4 Effect of Probiotics on MWM Spatial Memory (Probe Trial)</strong></h3>

<p>In the probe trial conducted on Day 6, we assessed the consolidation of memory for the original platform location (Figure 4-2).</p>

<p>**\[Figure 4-2: Performance of the three groups in the MWM probe trial. (A) Percentage of time spent in the target quadrant (%). (B) Number of platform crossings. Data are presented as Mean $\\pm$ SEM. \<em> $p \&lt; 0.05$, \</em>\* $p \&lt; 0.01$ vs. CON group.\]**</p>

<p><strong>\[Simulated Figure Description\]</strong></p>

<ul>
<li><strong>Figure 4-2A (Time in Target Quadrant %):</strong></li>
<li>One-way ANOVA revealed a significant difference among groups ($F(2, 27\) \= 6.9, p \&lt; 0.01$).</li>
<li>Tukey's post-hoc test showed that the <strong>Pro-H group</strong> spent significantly more time in the target quadrant (Simulated value: $42.5 \\pm 3.1\\%$) compared to the CON group (Simulated value: $28.0 \\pm 2.5\\%$) ($p \&lt; 0.01$).</li>
<li>The Pro-L group (Simulated value: $31.5 \\pm 2.8\\%$) showed no significant difference compared to the CON group.</li>
<li><strong>Figure 4-2B (Platform Crossings):</strong></li>
<li>One-way ANOVA revealed a significant difference among groups ($F(2, 27\) \= 4.8, p \&lt; 0.05$).</li>
<li>Tukey's post-hoc test showed that the <strong>Pro-H group</strong> had significantly more platform crossings (Simulated value: $4.8 \\pm 0.5$) compared to the CON group (Simulated value: $3.0 \\pm 0.4$) ($p \&lt; 0.05$).</li>
<li>The Pro-L group (Simulated value: $3.5 \\pm 0.6$) showed no significant difference compared to the CON group.</li>
</ul>

<p>Taken together, the probe trial results demonstrate that high-dose probiotic supplementation significantly enhanced spatial memory consolidation and search precision in mice.</p>

<h3 id="45effectofprobioticsonhippocampalneurotrophicandinflammatoryfactors"><strong>4.5 Effect of Probiotics on Hippocampal Neurotrophic and Inflammatory Factors</strong></h3>

<p>To explore the potential mechanisms by which probiotics improve cognitive function, we measured the levels of BDNF, TNF-$\\alpha$, and IL-6 in the hippocampal tissues after the MWM test (Figure 4-3).</p>

<p>**\[Figure 4-3: Protein expression levels of (A) BDNF, (B) TNF-$\\alpha$, and (C) IL-6 in the hippocampus of the three groups. Data are presented as Mean $\\pm$ SEM. \* $p \&lt; 0.05$ vs. CON group.\]**</p>

<p><strong>\[Simulated Figure Description\]</strong></p>

<ul>
<li><strong>Figure 4-3A (BDNF):</strong></li>
<li>One-way ANOVA showed a significant difference among groups ($F(2, 27\) \= 5.1, p \&lt; 0.05$).</li>
<li>Tukey's post-hoc test revealed that the <strong>Pro-H group</strong> had significantly higher hippocampal BDNF levels (Simulated value: 150.2 $\\pm 10.5$ pg/mg protein) than the CON group (Simulated value: 105.5 $\\pm 8.2$ pg/mg protein) ($p \&lt; 0.05$).</li>
<li>The Pro-L group (Simulated value: 120.8 $\\pm 9.5$ pg/mg protein) showed an increasing trend, but it did not reach significance.</li>
<li><strong>Figure 4-3B (TNF-$\\alpha$):</strong></li>
<li>One-way ANOVA showed a significant difference among groups ($F(2, 27\) \= 4.5, p \&lt; 0.05$).</li>
<li>Tukey's post-hoc test revealed that the <strong>Pro-H group</strong> had significantly lower hippocampal TNF-$\\alpha$ levels (Simulated value: 35.8 $\\pm 3.0$ pg/mg protein) than the CON group (Simulated value: 55.2 $\\pm 4.1$ pg/mg protein) ($p \&lt; 0.05$).</li>
<li>The Pro-L group (Simulated value: 48.0 $\\pm 3.8$ pg/mg protein) showed no significant difference compared to the CON group.</li>
<li><strong>Figure 4-3C (IL-6):</strong></li>
<li>There were no statistically significant differences in hippocampal IL-6 levels among the three groups (Simulated values: CON $15.1 \\pm 1.8$; Pro-L $13.5 \\pm 1.5$; Pro-H $12.8 \\pm 1.3$ pg/mg protein) ($F(2, 27\) \= 0.6, p \= 0.56$).</li>
</ul>

<p>The biochemical analysis suggests that high-dose probiotic supplementation may improve spatial learning and memory by co-currently <strong>upregulating hippocampal BDNF levels</strong> (promoting neuroplasticity) and <strong>downregulating hippocampal TNF-$\\alpha$ levels</strong> (inhibiting neuroinflammation).</p>

<hr/>

<h2 id="chapter5discussion"><strong>Chapter 5\. Discussion</strong></h2>

<p>This study aimed to investigate the effects of a specific probiotic combination (<em>L. acidophilus</em> and <em>B. bifidum</em>) on spatial learning and memory in healthy mice. The results show that 6 weeks of supplementation with a high dose ($1 \\times 10^9$ CFU/day) of probiotics significantly enhanced learning efficiency (shorter escape latency on Days 3-5) and memory consolidation (increased time in target quadrant and platform crossings in the probe trial) in the MWM. Mechanistically, this effect was accompanied by a significant increase in hippocampal BDNF levels and a significant decrease in TNF-$\\alpha$ levels.</p>

<h3 id="51mainfindingsandhypothesisverification"><strong>5.1 Main Findings and Hypothesis Verification</strong></h3>

<p>The main findings of this study support our research hypotheses H1 and H2. The MWM learning curve results (Figure 4-1) show that the Pro-H group exhibited superior learning efficiency compared to the control group starting from the middle phase of training (Day 3), suggesting that high-dose probiotic intervention may accelerate the acquisition of spatial cues and the formation of a cognitive map. More importantly, the probe trial results (Figure 4-2) confirmed that this learning effect translated into more robust long-term memory, as the Pro-H group demonstrated enhanced memory retrieval and search preference.</p>

<p>It is noteworthy that the low-dose group (Pro-L, $1 \\times 10^8$ CFU/day) did not show significant differences from the control group in any behavioral metrics. This reveals that the cognitive effects of the <em>L. acidophilus</em> and <em>B. bifidum</em> combination are clearly <strong>dose-dependent</strong>. This may also explain why some studies reviewed in the literature (e.g., Wang et al., 2023\) failed to observe significant effects, possibly because the dosages used did not reach the effective threshold.</p>

<h3 id="52comparisonwithliteratureandmechanisticdiscussion"><strong>5.2 Comparison with Literature and Mechanistic Discussion</strong></h3>

<p>The results of this study are consistent with previous findings in pathological models (e.g., AD or stress models) where probiotics improved cognitive function (Bonfili et al., 2017; Messaoudi et al., 2011), and extend these findings to a "cognitive enhancement" effect in a healthy state. The uniqueness of this study lies in revealing the effect of this specific <em>L. acidophilus</em> and <em>B. bifidum</em> combination in healthy mice.</p>

<p>Our further mechanistic investigation (Hypothesis H3) provides evidence supporting the modulation of cognitive function via the gut-brain axis.</p>

<h4 id="521probioticsbdnfandneuroplasticity"><strong>5.2.1 Probiotics, BDNF, and Neuroplasticity</strong></h4>

<p>This study found that hippocampal BDNF levels in the Pro-H group were significantly higher than in the control group (Figure 4-3A). BDNF is a core regulator of synaptic plasticity (LTP) in hippocampus-dependent learning and memory, especially for the MWM task (Poo, 2001). An increase in BDNF levels implies greater potential for neuroplasticity, which perfectly explains the superior performance of the Pro-H group in both the learning and memory phases of the MWM.</p>

<p>How do probiotics increase hippocampal BDNF? The gut-brain axis offers a plausible pathway. <em>Bifidobacterium</em> and <em>Lactobacillus</em> strains are known to be major producers of short-chain fatty acids (SCFAs), especially butyrate (Dalile et al., 2019). Butyrate, acting as a histone deacetylase (HDAC) inhibitor, has been shown to cross the blood-brain barrier and epigenetically modulate the expression of the BDNF gene in the hippocampus, thereby promoting its transcription (Govindarajan et al., 2011). Although our study did not directly measure SCFAs, the significant elevation of BDNF in the Pro-H group strongly suggests the activation of this "microbiota-metabolite-BDNF" pathway.</p>

<h4 id="522probioticsneuroinflammationandcognition"><strong>5.2.2 Probiotics, Neuroinflammation, and Cognition</strong></h4>

<p>The hippocampus is a brain region highly susceptible to inflammatory factors. Neuroinflammation, particularly the overexpression of pro-inflammatory cytokines like TNF-$\\alpha$, directly impairs synaptic plasticity (LTP) and inhibits neurogenesis, leading to cognitive decline (Ma et al., 2019). This study found that hippocampal TNF-$\\alpha$ levels in the Pro-H group were significantly lower than in the control group (Figure 4-3B).</p>

<p>Both <em>L. acidophilus</em> and <em>B. bifidum</em> have been reported to possess strong immunomodulatory and gut-barrier-protective functions (Pinto-Sanchez et al., 2017). By improving the integrity of the intestinal barrier, probiotics can effectively reduce the leakage of endotoxins like LPS from the gut into the circulation. This, in turn, reduces systemic low-grade inflammation and indirectly suppresses the "mirror inflammatory response" in the CNS. The reduction of TNF-$\\alpha$ in the Pro-H group suggests that the probiotic intervention may have created a "low-inflammation" microenvironment in the hippocampus, which is more conducive to learning and memory.</p>

<p>Interestingly, IL-6 levels showed no significant difference among the groups in our study. This might indicate that the anti-inflammatory effect of the <em>L. acidophilus</em> and <em>B. bifidum</em> combination is selective, primarily targeting the TNF-$\\alpha$ signaling pathway rather than the IL-6 pathway. Alternatively, it is possible that in a healthy state, baseline IL-6 levels are already low and not easily modulated further.</p>

<h3 id="53strengthslimitationsandfuturedirections"><strong>5.3 Strengths, Limitations, and Future Directions</strong></h3>

<h4 id="531strengthsofthestudy"><strong>5.3.1 Strengths of the Study</strong></h4>

<p>This study has several clear strengths: (1) <strong>Rigorous MWM Paradigm:</strong> We not only assessed the learning curve but also included a probe trial and a visible platform test, ensuring the reliability of the results. (2) <strong>Dose-Effect Exploration:</strong> By setting two different doses (low and high), we clarified the effective dose range for this strain combination. (3) <strong>Healthy Animal Model:</strong> We demonstrated the "cognitive enhancement" potential of probiotics in a non-pathological state, which has greater implications for wellness and supplementation than pathological "restoration."</p>

<h4 id="532limitationsofthestudy"><strong>5.3.2 Limitations of the Study</strong></h4>

<p>Despite the encouraging results, this study has limitations:</p>

<ol>
<li><strong>Depth of Mechanistic Investigation:</strong> We only measured BDNF and inflammatory factors as "outcome" indicators. The "process" indicators of the gut-brain axis, such as changes in gut microbiota composition, intestinal barrier integrity (e.g., Zonulin, Occludin), and levels of SCFAs or LPS in the blood, were not measured.</li>
<li><strong>Single-Sex Study:</strong> This study used only male mice. Given that sex dimorphism exists in both the gut microbiota and cognitive function, it is unclear whether these results can be generalized to female mice.</li>
<li><strong>Strain Colonization Analysis:</strong> We did not analyze whether the exogenously supplemented <em>L. acidophilus</em> and <em>B. bifidum</em> successfully and persistently colonized the gut, or if they merely exerted a metabolic regulatory effect while transiting.</li>
</ol>

<h4 id="533futureresearchdirections"><strong>5.3.3 Future Research Directions</strong></h4>

<p>Based on these limitations, future research could proceed in the following directions:</p>

<ol>
<li><strong>Mechanism Verification:</strong> 16S rRNA sequencing and metabolomics analyses should be included to clarify how the probiotic intervention reshapes the gut microbiota structure and the profile of key metabolites like SCFAs.</li>
<li><strong>Sex Differences:</strong> Parallel experiments should be conducted in female mice to compare the effects of probiotics on cognitive function between sexes.</li>
<li><strong>Long-Term Effects and Washout:</strong> Future studies should explore how long the cognitive enhancements persist after cessation of probiotic supplementation to assess the sustainability of the application.</li>
<li><strong>Translational Research:</strong> While animal studies provide strong evidence, rigorous human randomized controlled trials (RCTs) are ultimately needed to validate the efficacy of this strain combination in humans, particularly in healthy or mildly cognitively impaired populations.</li>
</ol>

<hr/>

<h2 id="chapter6conclusion"><strong>Chapter 6\. Conclusion</strong></h2>

<p>This study systematically evaluated the effects of a combination of <em>Lactobacillus acidophilus</em> and <em>Bifidobacterium bifidum</em> on spatial learning and memory in healthy C57BL/6J male mice. The conclusions are as follows:</p>

<ol>
<li>Supplementation with a high dose ($1 \\times 10^9$ CFU/day) of the <em>L. acidophilus</em> and <em>B. bifidum</em> combination for 6 consecutive weeks significantly enhances spatial learning efficiency and spatial memory consolidation in the Morris Water Maze in healthy mice.</li>
<li>The cognitive-improving effect of this probiotic combination is dose-dependent, as no significant effect was observed in the low-dose ($1 \\times 10^8$ CFU/day) group.</li>
<li>The underlying mechanism may involve the modulation of the gut-brain axis, manifested as a significant increase in hippocampal BDNF levels (enhancing neuroplasticity) and a significant decrease in the pro-inflammatory cytokine TNF-$\\alpha$ (inhibiting neuroinflammation).</li>
</ol>

<p>This study provides important preclinical experimental evidence for the <em>L. acidophilus</em> and <em>B. bifidum</em> combination as a novel "psychobiotic" or cognitive enhancer, offering valuable insights for the future development of functional foods or health supplements.</p>

<hr/>

<h2 id="chapter7references"><strong>Chapter 7\. References</strong></h2>

<p><strong>\[Note: This is a mixed list of real and simulated references to demonstrate APA format\]</strong></p>

<ul>
<li>Bird, C. M., &amp; Burgess, N. (2008). The hippocampus and spatial memory: Findings and future directions. <em>Nature Reviews Neuroscience, 9</em>(3), 182-194.</li>
<li>Bliss, T. V., &amp; Lømo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. <em>The Journal of Physiology, 232</em>(2), 331-356.</li>
<li>Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., ... &amp; Eleuteri, A. M. (2017). Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. <em>Scientific Reports, 7</em>(1), 2426\.</li>
<li>Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., ... &amp; Cryan, J. F. (2011). Ingestion of <em>Lactobacillus</em> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. <em>Proceedings of the National Academy of Sciences, 108</em>(38), 16050-16055.</li>
<li>Cryan, J. F., O'Riordan, K. J., Cowan, C. S., Sandhu, K. V., Bastiaanssen, T. F., Boehme, M., ... &amp; Dinan, T. G. (2019). The microbiota-gut-brain axis. <em>Physiological Reviews, 99</em>(4), 1877-2013.</li>
<li>Dalile, B., Van Oudenhove, L., Vervliet, B., &amp; Verbeke, K. (2019). The role of short-chain fatty acids in microbiota–gut–brain communication. <em>Nature Reviews Gastroenterology &amp; Hepatology, 16</em>(8), 461-478.</li>
<li>Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., &amp; Dinan, T. G. (2010). Effects of the probiotic <em>Bifidobacterium infantis</em> in the maternal separation model of depression. <em>Neuroscience, 170</em>(4), 1179-1188.</li>
<li>Dinan, T. G., Stanton, C., &amp; Cryan, J. F. (2013). Psychobiotics: a novel class of psychotropic. <em>Biological Psychiatry, 74</em>(10), 720-726.</li>
<li>Govindarajan, N., Agis-Balboa, R. C., Walter, J., Sananbenesi, F., &amp; Fischer, A. (2011). Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. <em>Journal of Alzheimer's Disease, 26</em>(1), 187-197.</li>
<li>Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., ... &amp; Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. <em>Nature Reviews Gastroenterology &amp; Hepatology, 11</em>(8), 506-514.</li>
<li>Ma, Q., Chen, S., Wang, T., Zhang, X., &amp; Wang, R. (2019). Neuroinflammation in the hippocampus of type 2 diabetic mice: The role of the gut microbiota. <em>Brain, Behavior, and Immunity, 80</em>, 681-693.</li>
<li>Mayer, E. A., Nance, K., &amp; Chen, S. (2022). The gut-brain axis. <em>Annual Review of Medicine, 73</em>, 439-453.</li>
<li>Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., ... &amp; Cazaubiel, J. M. (2011). Assessment of psychotropic-like properties of a probiotic formulation (<em>Lactobacillus helveticus</em> R0052 and <em>Bifidobacterium longum</em> R0175) in rats and human subjects. <em>British Journal of Nutrition, 105</em>(5), 755-764.</li>
<li>Morris, R. G. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. <em>Journal of Neuroscience Methods, 11</em>(1), 47-60.</li>
<li>O'Keefe, J., &amp; Nadel, L. (1978). <em>The Hippocampus as a Cognitive Map</em>. Oxford University Press.</li>
<li>Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., ... &amp; Bercik, P. (2017). Probiotic <em>Bifidobacterium longum</em> NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. <em>Gastroenterology, 153</em>(2), 448-459.</li>
<li>Poo, M. M. (2001). Neurotrophins as synaptic modulators. <em>Nature Reviews Neuroscience, 2</em>(1), 24-32.</li>
<li>\[Simulated\] Smith, A. B., et al. (2022). <em>Lactobacillus acidophilus</em> NCFM supplementation improves learning in healthy mice and modulates hippocampal BDNF. <em>Journal of Neuroinflammation, 19</em>(1), 112\.</li>
<li>Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., ... &amp; Zetterberg, H. (2017). Gut microbiome alterations in Alzheimer's disease. <em>Scientific Reports, 7</em>(1), 13537\.</li>
<li>\[Simulated\] Wang, L., et al. (2023). Limited impact of <em>Bifidobacterium animalis</em> subsp. <em>lactis</em> BB-12 on cognitive performance in healthy C57BL/6J mice. <em>Behavioural Brain Research, 440</em>, 114250\.</li>
<li>Wang, T., Hu, X., Wang, J., Zhao, J., Zhang, H., &amp; Chen, W. (2019). <em>Lactobacillus acidophilus</em> CUL60 modulates the kynurenine pathway and impacts cognitive function in a mouse model. <em>Brain, Behavior, and Immunity, 80</em>, 209-220.</li>
</ul>
    </div>
  </main>
</div>

<script>
// TOC data from Python (headings with levels and ids)
const TOC = [{"level": 2, "id": "嗜酸乳桿菌與雙歧桿菌補充對小鼠空間學習與記憶之影響", "title": "嗜酸乳桿菌與雙歧桿菌補充對小鼠空間學習與記憶之影響"}, {"level": 2, "id": "以莫里斯水迷宮實驗為依據", "title": "——以莫里斯水迷宮實驗為依據"}, {"level": 2, "id": "第一章緒論introduction", "title": "第一章 緒論 (Introduction)"}, {"level": 3, "id": "11研究背景與動機", "title": "1.1 研究背景與動機"}, {"level": 3, "id": "12研究目的", "title": "1.2 研究目的"}, {"level": 3, "id": "13研究假設", "title": "1.3 研究假設"}, {"level": 2, "id": "第二章文獻探討literaturereview", "title": "第二章 文獻探討 (Literature Review)"}, {"level": 3, "id": "21空間學習與記憶的生物學基礎", "title": "2.1 空間學習與記憶的生物學基礎"}, {"level": 4, "id": "211學習記憶的分子機制與海馬迴", "title": "2.1.1 學習記憶的分子機制與海馬迴"}, {"level": 4, "id": "212腦源性神經營養因子bdnf的角色", "title": "2.1.2 腦源性神經營養因子 (BDNF) 的角色"}, {"level": 4, "id": "213空間學習的核心腦區海馬迴", "title": "2.1.3 空間學習的核心腦區：海馬迴"}, {"level": 3, "id": "22莫里斯水迷宮morriswatermazemwm實驗方法", "title": "2.2 莫里斯水迷宮 (Morris Water Maze, MWM) 實驗方法"}, {"level": 3, "id": "23益生菌probiotics及其在腸-腦軸線中的作用", "title": "2.3 益生菌 (Probiotics) 及其在腸-腦軸線中的作用"}, {"level": 4, "id": "231益生菌與精神益生菌的定義", "title": "2.3.1 益生菌與精神益生菌的定義"}, {"level": 4, "id": "232腸-腦軸線gut-brainaxis的雙向溝通路徑", "title": "2.3.2 腸-腦軸線 (Gut-Brain Axis) 的雙向溝通路徑"}, {"level": 4, "id": "233嗜酸乳桿菌lacidophilus與雙歧桿菌bbifidum的特性", "title": "**2.3.3 嗜酸乳桿菌 (L. acidophilus) 與雙歧桿菌 (B. bifidum) 的特性**"}, {"level": 3, "id": "24益生菌補充對學習與記憶的影響相關實證研究", "title": "2.4 益生菌補充對學習與記憶的影響：相關實證研究"}, {"level": 3, "id": "25研究缺口與本研究的定位", "title": "2.5 研究缺口與本研究的定位"}, {"level": 2, "id": "第三章研究方法materialsandmethods", "title": "第三章 研究方法 (Materials and Methods)"}, {"level": 3, "id": "31實驗動物", "title": "3.1 實驗動物"}, {"level": 4, "id": "311動物品系數量與飼養條件", "title": "3.1.1 動物品系、數量與飼養條件"}, {"level": 4, "id": "312分組與隨機化", "title": "3.1.2 分組與隨機化"}, {"level": 3, "id": "32實驗介入物製備與投餵", "title": "3.2 實驗介入物製備與投餵"}, {"level": 4, "id": "321菌株來源與製備", "title": "3.2.1 菌株來源與製備"}, {"level": 4, "id": "322劑量與投餵方式", "title": "3.2.2 劑量與投餵方式"}, {"level": 3, "id": "33莫里斯水迷宮morriswatermazemwm實驗", "title": "3.3 莫里斯水迷宮 (Morris Water Maze, MWM) 實驗"}, {"level": 4, "id": "331設備與環境設置", "title": "3.3.1 設備與環境設置"}, {"level": 4, "id": "332實驗流程與指標", "title": "3.3.2 實驗流程與指標"}, {"level": 3, "id": "34組織採樣與生化分析", "title": "3.4 組織採樣與生化分析"}, {"level": 4, "id": "341海馬迴組織勻漿", "title": "3.4.1 海馬迴組織勻漿"}, {"level": 4, "id": "342elisa檢測", "title": "3.4.2 ELISA 檢測"}, {"level": 3, "id": "35統計分析", "title": "3.5 統計分析"}, {"level": 2, "id": "第四章研究結果results", "title": "第四章 研究結果 (Results)"}, {"level": 3, "id": "41益生菌介入對小鼠一般狀況的影響", "title": "4.1 益生菌介入對小鼠一般狀況的影響"}, {"level": 3, "id": "42mwm視力與動機測試結果", "title": "4.2 MWM 視力與動機測試結果"}, {"level": 3, "id": "43益生菌對mwm空間學習定位巡迴訓練的影響", "title": "4.3 益生菌對 MWM 空間學習（定位巡迴訓練）的影響"}, {"level": 3, "id": "44益生菌對mwm空間記憶探測試驗的影響", "title": "4.4 益生菌對 MWM 空間記憶（探測試驗）的影響"}, {"level": 3, "id": "45益生菌對海馬迴神經因子水平的影響", "title": "4.5 益生菌對海馬迴神經因子水平的影響"}, {"level": 2, "id": "第五章討論discussion", "title": "第五章 討論 (Discussion)"}, {"level": 3, "id": "51主要發現與研究假設驗證", "title": "5.1 主要發現與研究假設驗證"}, {"level": 3, "id": "52結果與文獻的對比及機制探討", "title": "5.2 結果與文獻的對比及機制探討"}, {"level": 4, "id": "521益生菌bdnf與神經可塑性", "title": "5.2.1 益生菌、BDNF 與神經可塑性"}, {"level": 4, "id": "522益生菌神經炎症與認知", "title": "5.2.2 益生菌、神經炎症與認知"}, {"level": 3, "id": "53研究的優勢限制與未來方向", "title": "5.3 研究的優勢、限制與未來方向"}, {"level": 4, "id": "531研究優勢", "title": "5.3.1 研究優勢"}, {"level": 4, "id": "532研究限制", "title": "5.3.2 研究限制"}, {"level": 4, "id": "533未來研究方向", "title": "5.3.3 未來研究方向"}, {"level": 2, "id": "第六章結論conclusion", "title": "第六章 結論 (Conclusion)"}, {"level": 2, "id": "第七章參考文獻references", "title": "第七章 參考文獻 (References)"}, {"level": 2, "id": "effectsofprobioticsupplementationlactobacillusacidophilusandbifidobacteriumbifidumonspatiallearningandmemoryinmiceevidencefromthemorriswatermaze", "title": "**Effects of Probiotic Supplementation (Lactobacillus acidophilus and Bifidobacterium bifidum) on Spatial Learning and Memory in Mice: Evidence from the Morris Water Maze**"}, {"level": 2, "id": "chapter1introduction", "title": "Chapter 1\\. Introduction"}, {"level": 3, "id": "11backgroundandrationale", "title": "1.1 Background and Rationale"}, {"level": 3, "id": "12researchobjectives", "title": "1.2 Research Objectives"}, {"level": 3, "id": "13researchhypotheses", "title": "1.3 Research Hypotheses"}, {"level": 2, "id": "chapter2literaturereview", "title": "Chapter 2\\. Literature Review"}, {"level": 3, "id": "21thebiologicalbasisofspatiallearningandmemory", "title": "2.1 The Biological Basis of Spatial Learning and Memory"}, {"level": 4, "id": "211molecularmechanismsoflearningandthehippocampus", "title": "2.1.1 Molecular Mechanisms of Learning and the Hippocampus"}, {"level": 4, "id": "212theroleofbrain-derivedneurotrophicfactorbdnf", "title": "2.1.2 The Role of Brain-Derived Neurotrophic Factor (BDNF)"}, {"level": 4, "id": "213thehippocampusthecorebrainregionforspatiallearning", "title": "2.1.3 The Hippocampus: The Core Brain Region for Spatial Learning"}, {"level": 3, "id": "22themorriswatermazemwmmethodology", "title": "2.2 The Morris Water Maze (MWM) Methodology"}, {"level": 3, "id": "23probioticsandtheirroleinthegut-brainaxis", "title": "2.3 Probiotics and Their Role in the Gut-Brain Axis"}, {"level": 4, "id": "231definitionsofprobioticsandpsychobiotics", "title": "2.3.1 Definitions of Probiotics and Psychobiotics"}, {"level": 4, "id": "232bidirectionalcommunicationpathwaysofthegut-brainaxis", "title": "2.3.2 Bidirectional Communication Pathways of the Gut-Brain Axis"}, {"level": 4, "id": "233characteristicsoflacidophilusandbbifidum", "title": "**2.3.3 Characteristics of L. acidophilus and *B. bifidum***"}, {"level": 3, "id": "24empiricalstudiesonprobioticsupplementationandcognition", "title": "2.4 Empirical Studies on Probiotic Supplementation and Cognition"}, {"level": 3, "id": "25researchgapandstudypositioning", "title": "2.5 Research Gap and Study Positioning"}, {"level": 2, "id": "chapter3materialsandmethods", "title": "Chapter 3\\. Materials and Methods"}, {"level": 3, "id": "31experimentalanimals", "title": "3.1 Experimental Animals"}, {"level": 4, "id": "311animalstrainnumberandhousing", "title": "3.1.1 Animal Strain, Number, and Housing"}, {"level": 4, "id": "312groupingandrandomization", "title": "3.1.2 Grouping and Randomization"}, {"level": 3, "id": "32probioticpreparationandadministration", "title": "3.2 Probiotic Preparation and Administration"}, {"level": 4, "id": "321strainsourceandpreparation", "title": "3.2.1 Strain Source and Preparation"}, {"level": 4, "id": "322dosageandadministration", "title": "3.2.2 Dosage and Administration"}, {"level": 3, "id": "33morriswatermazemwmtest", "title": "3.3 Morris Water Maze (MWM) Test"}, {"level": 4, "id": "331apparatusandenvironment", "title": "3.3.1 Apparatus and Environment"}, {"level": 4, "id": "332experimentalprocedureandmetrics", "title": "3.3.2 Experimental Procedure and Metrics"}, {"level": 3, "id": "34tissuesamplingandbiochemicalanalysis", "title": "3.4 Tissue Sampling and Biochemical Analysis"}, {"level": 4, "id": "341hippocampaltissuehomogenization", "title": "3.4.1 Hippocampal Tissue Homogenization"}, {"level": 4, "id": "342elisadetection", "title": "3.4.2 ELISA Detection"}, {"level": 3, "id": "35statisticalanalysis", "title": "3.5 Statistical Analysis"}, {"level": 2, "id": "chapter4results", "title": "Chapter 4\\. Results"}, {"level": 3, "id": "41effectofprobioticinterventionongeneralconditionofmice", "title": "4.1 Effect of Probiotic Intervention on General Condition of Mice"}, {"level": 3, "id": "42mwmvisualandmotivationaltestresults", "title": "4.2 MWM Visual and Motivational Test Results"}, {"level": 3, "id": "43effectofprobioticsonmwmspatiallearningacquisitionphase", "title": "4.3 Effect of Probiotics on MWM Spatial Learning (Acquisition Phase)"}, {"level": 3, "id": "44effectofprobioticsonmwmspatialmemoryprobetrial", "title": "4.4 Effect of Probiotics on MWM Spatial Memory (Probe Trial)"}, {"level": 3, "id": "45effectofprobioticsonhippocampalneurotrophicandinflammatoryfactors", "title": "4.5 Effect of Probiotics on Hippocampal Neurotrophic and Inflammatory Factors"}, {"level": 2, "id": "chapter5discussion", "title": "Chapter 5\\. Discussion"}, {"level": 3, "id": "51mainfindingsandhypothesisverification", "title": "5.1 Main Findings and Hypothesis Verification"}, {"level": 3, "id": "52comparisonwithliteratureandmechanisticdiscussion", "title": "5.2 Comparison with Literature and Mechanistic Discussion"}, {"level": 4, "id": "521probioticsbdnfandneuroplasticity", "title": "5.2.1 Probiotics, BDNF, and Neuroplasticity"}, {"level": 4, "id": "522probioticsneuroinflammationandcognition", "title": "5.2.2 Probiotics, Neuroinflammation, and Cognition"}, {"level": 3, "id": "53strengthslimitationsandfuturedirections", "title": "5.3 Strengths, Limitations, and Future Directions"}, {"level": 4, "id": "531strengthsofthestudy", "title": "5.3.1 Strengths of the Study"}, {"level": 4, "id": "532limitationsofthestudy", "title": "5.3.2 Limitations of the Study"}, {"level": 4, "id": "533futureresearchdirections", "title": "5.3.3 Future Research Directions"}, {"level": 2, "id": "chapter6conclusion", "title": "Chapter 6\\. Conclusion"}, {"level": 2, "id": "chapter7references", "title": "Chapter 7\\. References"}];

const tocEl = document.getElementById('toc');
function renderTOC(filter="") {
  tocEl.innerHTML = "";
  const ul = document.createElement('ul');
  TOC.forEach(item => {
    if (filter && !item.title.toLowerCase().includes(filter.toLowerCase())) return;
    const li = document.createElement('li');
    li.className = "toc-l" + item.level;
    const a = document.createElement('a');
    a.href = "#" + item.id;
    a.textContent = item.title;
    li.appendChild(a);
    ul.appendChild(li);
  });
  tocEl.appendChild(ul);
}
renderTOC();

// Scroll spy
const links = () => Array.from(tocEl.querySelectorAll('a'));
const headings = () => Array.from(document.querySelectorAll('.doc h1, .doc h2, .doc h3, .doc h4, .doc h5, .doc h6'));
let obs = new IntersectionObserver((entries) => {
  entries.forEach(entry => {
    if (entry.isIntersecting) {
      links().forEach(a => a.classList.remove('active'));
      const id = entry.target.getAttribute('id');
      const active = tocEl.querySelector(`a[href="#${id}"]`);
      if (active) active.classList.add('active');
    }
  });
}, { rootMargin: "-60% 0px -40% 0px", threshold: [0, 1] });
headings().forEach(h => obs.observe(h));

// Filter
const filt = document.getElementById('tocFilter');
filt.addEventListener('input', (e) => renderTOC(e.target.value));
document.addEventListener('keydown', (e) => {
  if ((e.ctrlKey || e.metaKey) && e.key.toLowerCase() === 'k') {
    e.preventDefault();
    filt.focus();
    filt.select();
  }
});

// Collapse/expand paragraphs under each heading by toggling a class
const btn = document.getElementById('collapseAll');
let collapsed = false;
btn.addEventListener('click', () => {
  collapsed = !collapsed;
  document.querySelectorAll('.doc h1, .doc h2, .doc h3, .doc h4, .doc h5, .doc h6').forEach(h => {
    let nxt = h.nextElementSibling;
    while (nxt && !/^H[1-6]$/.test(nxt.tagName)) {
      nxt.style.display = collapsed ? 'none' : '';
      nxt = nxt.nextElementSibling;
    }
  });
});
</script>
</body>
</html>
